WO1999047082A1 - Percutaneous prosthetic spinal disc nucleus and method of manufacture - Google Patents

Percutaneous prosthetic spinal disc nucleus and method of manufacture Download PDF

Info

Publication number
WO1999047082A1
WO1999047082A1 PCT/US1999/005757 US9905757W WO9947082A1 WO 1999047082 A1 WO1999047082 A1 WO 1999047082A1 US 9905757 W US9905757 W US 9905757W WO 9947082 A1 WO9947082 A1 WO 9947082A1
Authority
WO
WIPO (PCT)
Prior art keywords
polymer core
hydrogel
nucleus
spinal disc
constraining jacket
Prior art date
Application number
PCT/US1999/005757
Other languages
French (fr)
Inventor
Robert L. Assell
Charles D. Ray
Original Assignee
Raymedica, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raymedica, Inc. filed Critical Raymedica, Inc.
Priority to DE69935425T priority Critical patent/DE69935425T2/en
Priority to CA002323922A priority patent/CA2323922C/en
Priority to AU30076/99A priority patent/AU742901B2/en
Priority to BR9908824-0A priority patent/BR9908824A/en
Priority to EP99911436A priority patent/EP1063948B1/en
Priority to JP2000536325A priority patent/JP2002506678A/en
Publication of WO1999047082A1 publication Critical patent/WO1999047082A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/441Joints for the spine, e.g. vertebrae, spinal discs made of inflatable pockets or chambers filled with fluid, e.g. with hydrogel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30942Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30965Reinforcing the prosthesis by embedding particles or fibres during moulding or dipping
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442Intervertebral or spinal discs, e.g. resilient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/3008Properties of materials and coating materials radio-opaque, e.g. radio-opaque markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/3011Cross-sections or two-dimensional shapes
    • A61F2002/30138Convex polygonal shapes
    • A61F2002/30156Convex polygonal shapes triangular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30224Three-dimensional shapes cylindrical
    • A61F2002/30235Three-dimensional shapes cylindrical tubular, e.g. sleeves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30291Three-dimensional shapes spirally-coiled, i.e. having a 2D spiral cross-section
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30291Three-dimensional shapes spirally-coiled, i.e. having a 2D spiral cross-section
    • A61F2002/30293Cylindrical body made by spirally rolling up a sheet or a strip around itself
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30329Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2002/30461Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30535Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30579Special structural features of bone or joint prostheses not otherwise provided for with mechanically expandable devices, e.g. fixation devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30535Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30617Visible markings for adjusting, locating or measuring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30841Sharp anchoring protrusions for impaction into the bone, e.g. sharp pins, spikes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30878Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442Intervertebral or spinal discs, e.g. resilient
    • A61F2002/444Intervertebral or spinal discs, e.g. resilient for replacing the nucleus pulposus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2002/448Joints for the spine, e.g. vertebrae, spinal discs comprising multiple adjacent spinal implants within the same intervertebral space or within the same vertebra, e.g. comprising two adjacent spinal implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2002/4495Joints for the spine, e.g. vertebrae, spinal discs having a fabric structure, e.g. made from wires or fibres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0017Angular shapes
    • A61F2230/0023Angular shapes triangular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0069Three-dimensional shapes cylindrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0091Three-dimensional shapes helically-coiled or spirally-coiled, i.e. having a 2-D spiral cross-section
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0097Visible markings, e.g. indicia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers

Definitions

  • the present invention relates to a prosthetic spinal disc nucleus. More particularly, it relates to a percutaneously implantable, capsule-shaped intradiscal prosthesis and a method of manufacture therefor.
  • the vertebral spine is the axis of the skeleton upon which all of the body parts "hang".
  • the normal spine has seven cervical, twelve thoracic and five lumbar segments.
  • the lumbar segments sit upon the sacrum, which then attaches to the pelvis, in turn supported by the hip and leg bones.
  • the bony vertebral bodies of the spine are separated by intervertebral discs, which act as joints, but allow known degrees of flexion, extension, lateral bending and axial rotation.
  • the typical vertebra has a thick interior bone mass called the vertebral body, with a neural (vertebral) arch that arises from a posterior surface of the vertebral body.
  • Each narrow arch combines with the posterior surface of the vertebral body and encloses a vertebral foramen.
  • the vertebral foramina of adjacent vertebrae are aligned to form a vertebral canal, through which the spinal sac, cord and nerve rootlets pass.
  • the portion of the neural arch that extends posteriorly and acts to protect a posterior side of the spinal cord is known as the lamina. Projecting from the posterior region of the neural arch is a spinous process. The centra of adjacent vertebrae are supported by the intervertebral disc.
  • the intervertebral disc primarily serves as a mechanical cushion between the vertebral bones, permitting controlled motions within vertebral segments of the axial skeleton.
  • the normal disc is a unique, mixed structure, comprised of three component tissues: The nucleus pulposus (“nucleus”), the anulus fibrosus (“anulus”), and two opposing vertebral end plates.
  • the two vertebral end plates are each composed of thin cartilage overlying a thin layer of hard, cortical bone which attaches to the spongy, richly vascular, cancellous bone of the vertebral body.
  • the end plates thus serve to attach adjacent vertebrae to the disc. In other words, a transitional zone is created by the end plates between the malleable disc and the bony vertebrae.
  • the anulus of the disc is a tough, outer fibrous ring that binds together adjacent vertebrae.
  • This fibrous portion which is much like a laminated automobile tire, is generally about 10 to 15 millimeters in height and about 15 to 20 millimeters in thickness.
  • the fibers of the anulus consist of 15 to 20 overlapping multiple plies, and are inserted into the superior and inferior vertebral bodies at roughly a 30 angle in both directions. This configuration particularly resists torsion, as about half of the angulated fibers will tighten when the vertebrae rotate in either direction, relative to each other.
  • the laminated plies are less firmly attached to each other.
  • the healthy nucleus is largely a gel-like substance having a high water content, and similar to air in a tire, serves to keep the anulus tight yet flexible.
  • the nucleus-gel moves slightly within the anulus when force is exerted on the adjacent vertebrae with bending, lifting, etc.
  • the nucleus and the inner portion of the anulus have no direct blood supply.
  • the principal nutritional source for the central disc arises from circulation within the vertebral body. Microscopic, villous-like fmgerlings of the nuclear and anular tissue penetrate the vertebral end plates and allow fluids to pass from the blood across the cell membrane of the fmgerlings and then inward to the nuclear tissue. These fluids are primarily body water and the smallest molecular weight nutrients and electrolytes.
  • the natural physiology of the nucleus promotes these fluids being brought into and released from the nucleus by cyclic loading.
  • fluid When fluid is forced out of the nucleus, it passes again through the end plates and then back into the richly vascular vertebral bodies.
  • the cyclic loading amounts to daily variations in applied pressure on the vertebral column (e.g., body weight and muscle pull) causing the nucleus to expel fluids, followed by periods of relaxation and rest, resulting in fluid absorption or swelling by the nucleus.
  • the nucleus changes volume under loaded and non-loaded conditions.
  • the resulting tightening and loosening effect on the anulus stimulates normal anulus collagen fibers to remain healthy or to regenerate when torn, a process found in all normal ligaments related to body joints.
  • the ability of the nucleus to release and imbibe fluids allows the spine to alter its height and flexibility through periods of loading or relaxation. Normal loading cycling is thus an effective nucleus and inner anulus tissue fluid pump, not only bringing in fresh nutrients, but perhaps more importantly, removing the accumulated, potentially autotoxic by-products of metabolism.
  • the spinal disc may be displaced or damaged due to trauma or a disease process.
  • a disc herniation occurs when the anulus fibers are weakened or torn and the inner tissue of the nucleus becomes permanently bulged, distended, or extruded out of its normal, internal anular confines.
  • the mass of a herniated or "slipped" nucleus can compress a spinal nerve, resulting in leg pain, loss of muscle control, or even paralysis.
  • the nucleus loses its water binding ability and deflates, as though the air had been let out of a tire. Subsequently, the height of the nucleus decreases, causing the anulus to buckle in areas where the laminated plies are loosely bonded.
  • the disc space will narrow and may lose much of its normal stability.
  • the nucleus is removed and the two adjacent vertebrae surgically fused together. While this treatment alleviates the pain, all discal motion is lost in the fused segment.
  • this procedure places greater stresses on the discs adjacent to the fused segment as they compensate for the lack of motion, perhaps leading to premature degeneration of those adjacent discs.
  • a more desirable solution entails replacing in part or as a whole the damaged nucleus with a suitable prosthesis having the ability to complement the normal height and motion of the disc while stimulating the natural disc physiology.
  • Restoring the nutrition-flushing cycle of a natural disc is important for a prosthetic spinal disc nucleus to be successful.
  • Vascular circulation and nerve supply to the disc is limited to the outer layers of the anulus, never penetrating more than a few millimeters, or about five of the anular plies.
  • Most of the nutrition for the inner anulus and nucleus is provided by diffusion through the end plates of the vertebral bodies and by the important pumping action between the partially loaded and fully loaded conditions of the disc. If the nutritional cycle is impeded, a variety of degenerative changes may occur.
  • Nutrition to the inner disc slowly ceases, resulting in intradiscal build-up of acids and autotoxins, and other changes. This is followed by nuclear and anular fiber degeneration, shrinkage of the nucleus, segmental laxity, spur formation, disc space collapse and perhaps spontaneous fusion. Additionally, significantly disabling back pain may develop.
  • prosthetic discs As an alternative to vertebral fusion, various prosthetic discs have been developed.
  • the first prostheses embodied a wide variety of ideas, such as ball bearings, springs, metal spikes and other perceived aids.
  • These prosthetic discs were designed to replace the entire intervertebral disc space and were large and rigid. Beyond the questionable applicability of these devices is the inherent difficulties encountered during implantation. Due to their size and inflexibility, these devices required an anterior implantation approach as the barriers presented by the lamina and, more importantly, the spinal cord and nerve rootlets during posterior implantation could not be avoided. Recently, smaller and more flexible prosthetic nucleus devices have been developed. With the reduction in prosthesis size, the ability to work around the spinal cord and nerve rootlets during posterior implantation has become possible.
  • Bao et al. U.S. Patent No. 5,047,055 discloses a prosthetic nucleus for a vertebral disc made of a hydrogel material. Prior to implant, the hydrogel material is implanted into the intradiscal space in a dehydrated state. The hydrogel material then hydrates to a shape conforming to the natural nucleus.
  • Bao et al. U.S. Patent No. 5,192,326, describes a prosthetic nucleus comprised of a solid hydrogel core or a multiplicity of hydrogel beads surrounded by a membrane. Once again, this prosthesis is implanted into the disc space in a dehydrated state, subsequently hydrating to a shape conforming to the natural nucleus.
  • the Bao devices rely exclusively on the anulus for expansion constraint, there is a distinct possibility that the prosthesis may migrate out from the nucleus cavity through the hole in the anulus.
  • the hydrogel bead-based prosthesis requires molding hydrogel beads to a size of 40-120 m. Beyond the costs associated with creating an appropriately sized mold, the spherical-shaped beads inherently result in undesirable spacing between individual beads. In other words, upon hydration, the hydrogel beads are not compactly stacked, resulting in a prosthesis that may not provide necessary intradiscal support. Degenerated, painfully disabling interspinal discs are a major economic and social problem for patients, their families, employers and the public at large.
  • the present invention provides an elongated prosthetic spinal disc nucleus for implantation deep inside a nucleus cavity of a human disc space and a method of manufacturing such a prosthesis.
  • the nucleus cavity is defined by an opposing pair of vertebral bodies, forming opposing endplates, and an anulus.
  • the prosthesis is comprised of a substantially inelastic constraining jacket maintaining an amorphous polymer core.
  • the constraining jacket is preferably flexible but inelastic, having a generally fixed maximum volume that is less than a volume of the nucleus cavity.
  • the maximum volume of the constraining jacket is determined by a generally fixed circumference and length. Further, the constraining jacket defines a height corresponding to a plane substantially perpendicular to the opposing endplates.
  • the amorphous polymer core is flowable in at least a first state.
  • the amorphous polymer core is disposed within the constraining jacket and is configured such that upon insertion, the amorphous polymer core fills an initial volume of the constraining jacket and creates an internal pressure within the constraining jacket.
  • the constraining jacket is configured to transition from the initial volume toward the maximum volume, increasing substantially in height in response to the internal pressure.
  • the amorphous polymer core is a hydrogel configured to expand from an unhydrated state to a hydrated state. With this embodiment, the maximum volume of the constraining jacket is greater than a volume of the hydrogel in the unhydrated state, but less than a theoretical, unconstrained volume of the hydrogel in the hydrated state.
  • the internal pressure within the constraining jacket is a swelling pressure of the hydrogel transitioning from the unhydrated state to the hydrated state.
  • the preferred method of manufacturing a prosthetic spinal disc nucleus in accordance with the present invention includes providing a substantially inelastic constraining jacket and an amorphous polymer core that is flowable in at least a first state.
  • the constraining jacket has a generally fixed maximum volume determined by a fixed circumference and length and defines a height corresponding to a transverse plane of the nucleus cavity. The maximum volume of the constraining jacket is less than a volume of the nucleus cavity.
  • the amorphous polymer core in a flowable state, is inserted into the constraining jacket and fills an initial volume of the consfraiiring jacket.
  • An internal pressure is generated within the constraining jacket.
  • the constraining jacket transitions from the initial volume toward the maximum volume and increases substantially in height in response to the internal pressure.
  • One preferred application includes implanting a properly sized constraining jacket into a nucleus cavity of a damaged disc space.
  • the amorphous polymer core in a flowable state, is then inserted into the constraining jacket, via a syringe or small diameter catheter. This insertion preferably occurs percutaneously.
  • the amorphous polymer core is placed within the constraining jacket prior to implant.
  • the prosthetic spinal disc nucleus of the present invention reestablishes near-normal disc height and near-normal anulus position and function. Additionally, by utilizing an amorphous polymer core, the prosthetic spinal disc nucleus is compliant such that the prosthesis will conform to the available internal shape of the nucleus cavity, although it does not encompass the entire cavity. Finally, the constraining jacket serves to direct and constrain the amorphous polymer core, minimizing transverse forces on an interior of the anulus.
  • FIG. 1 is a perspective view of a prosthetic spinal disc nucleus, including a cut-away view showing a portion of a core, in accordance with the present invention
  • FIG. 2 is a front sectional view of the prosthetic spinal disc nucleus along the line 2-2 of FIG. 1;
  • FIG. 3 is a posterior view of a spinal segment including a degenerated discal area
  • FIG. 4 is a posterior view of the spinal segment of FIG. 3 showing a flap that has been cut through an anulus
  • FIG. 5 is a top, sectional view of a human disc space having a prosthetic spinal disc nucleus in accordance with the present invention implanted;
  • FIG. 6 is a posterior view of a spinal segment including a degenerated discal area
  • FIG. 7 is a posterior view of the spinal segment of FIG. 6 showing two flaps that have been cut through an anulus
  • FIG. 8 is a top, sectional view of a human disc space having two prosthetic spinal disc nuclei implanted by an alternative method in accordance with the present invention
  • FIG. 9 is a perspective view of an alternative embodiment of a prosthetic spinal disc nucleus, including a cut-away view showing a portion of a core, in accordance with the present invention
  • FIG. 10 is a front sectional view of the prosthetic spinal disc nucleus of FIG. 9 along the line 10-10; and FIGS. 11-15 illustrate steps of fabricating the alternative prosthetic spinal disc nucleus of FIG. 9 in accordance with the present invention.
  • the prosthetic spinal disc nucleus 20 is a capsule-shaped body comprised of an amorphous polymer core 22 and a constraining jacket 24.
  • the constraining jacket 24 is defined by an anterior end 26 and a posterior end 28, and is secured around the amorphous polymer core 22 by an anterior closure 30 located at the anterior end 26 and a posterior closure 32 located at the posterior end 28.
  • the amorphous polymer core 22 is preferably configured to be flowable in at least a first state.
  • the amorphous polymer core 22 is inserted into the constraining jacket 24, generating an internal pressure.
  • the constraining jacket 24 is configured to be flexible, but substantially inelastic such that the prosthetic spinal disc nucleus 20 increases in a desired direction in response to the internal pressure.
  • A. Amorphous Polymer Core 22 As A Hydrogel the amorphous polymer core 22 is a hydrogel configured to imbibe fluids, expanding from an unhydrated state to a hydrated state.
  • the hydrogel material is preferably formulated as a mixture of hydrogel polyacrylonitrile.
  • acrylamide and acrylonitrile (block co- polymer) are used.
  • the hydrogel material used for the amorphous polymer core 22 can be any hydrophilic acrylate derivative with a unique multiblock copolymer structure or any other hydrogel material having the ability to deform and reform in a desired fashion in response to placement and removal of loads. Even further, a biologically-safe polymer or elastomer that can imbibe fluids while maintaining its structure under various stresses is acceptable.
  • the amorphous polymer core 22 can be formulated as a mixture of polyvinyl alcohol and water.
  • the hydrogel material used for the amorphous polymer core 22 is manufactured under the trade name HYP AN® by Hymedix International, Inc. of Dayton, NJ.
  • the hydrogel material of the amorphous polymer core 22 is in a powder form.
  • the amorphous polymer core 22 preferably consists of a plurality of fine, irregularly shaped grains of hydrogel material.
  • the grains are non-spherical. With this configuration, each of the grains of hydrogel material has a width on the order of 8xl0 "3 inches.
  • Acceptable powder hydrogel material is available, for example, under the tradename HYP AN® from Hymedix International, Inc. of Dayton, NJ.
  • the hydrogel powder may be used as supplied by the manufacturer, or may be processed to generally orientate the shape of the individual grains.
  • the individual grains have a flat side, and are defined by a height less than a length and a width.
  • each of the flattened hydrogel powder grains will preferably have a height, length and width aspect ratio of approximately 1:5:5. With this configuration, the flattened hydrogel powder grains will lie against one another when compacted, and have a tendency to slide.
  • the shape of individual grains of the amorphous polymer core 22 may be further controlled, as described in greater detail below.
  • the amorphous polymer core 22 has a fluid-like attribute such that in at least one state the amorphous polymer core 22 will flow.
  • the individual grains are relatively small such that the powder as a whole "flows". This flowable attribute can be enhanced by coating the individual grains with a low friction material, such as polyvinyl alcohol or polyacrylonitrite.
  • the amorphous polymer core 22 has been preferably described as consisting of a dry, hydrogel powder, other forms are acceptable.
  • the amorphous polymer core 22 may consist of a hydrogel powder, as described above, suspended in a viscous liquid.
  • the viscous liquid is glycerine, although other similar fluid carriers able to suspend hydrogel powder can be used.
  • the amorphous polymer core 22 may be a fluid hydrogel, consisting of dry hydrogel powder, as described above, dissolved in a solvent, such as Dimethyl Sulfoxide (DMSO). Other solvents able to keep the hydrogel polymer chains mobile are also available.
  • DMSO Dimethyl Sulfoxide
  • the fluid hydrogel Prior to exposure to water (such as in a disc space), the fluid hydrogel flows. However, upon contact with water, the solvent is replaced by water, causing the fluid hydrogel to permanently congeal or solidify. Thus, upon hydration, the fluid hydrogel will fuse into solid form. It should be understood that the solid form of the fluid hydrogel will still have a conformability characteristic, such that the amorphous polymer core 22 will deform slightly in response to various loads.
  • the amorphous polymer core 22 expands from a dehydrated state (prior to implant) to a hydrated state (following implant). In the dehydrated state, the amorphous polymer core 22 flows, such that it can be poured or injected into the constraining jacket 24, as described below.
  • the constraining jacket 24 is preferably a capsule-shaped tube made of a tightly-woven, high molecular weight, high tenacity polymeric fabric.
  • high molecular weight polyethylene is used as the weave material for the constraining jacket 24.
  • polyester or any other high molecular weight polyethylene is used as the weave material for the constraining jacket 24.
  • the constraining jacket 24 is preferably made of fibers that have been highly orientated along their length. As a result, the constraining jacket 24 material, while flexible, has little elasticity or stretch and a generally fixed maximum volume.
  • the maximum volume of the constraining jacket 24 is defined by a generally fixed length and circumference. Additionally, with reference to FIG. 2, the constraining jacket 24 defines a height and a width. The height of the constraining jacket 24 corresponds to a transverse plane of a nucleus cavity (not shown) and is represented by the "x" plane in FIG. 2. Conversely, the width of the constraining jacket 24 corresponds to the sagittal plane of the nucleus cavity and is represented by the "y" plane in FIG. 2.
  • the preferred woven construction of the constraining jacket 24 creates a plurality of small openings 34, as shown in FIG. 2.
  • the plurality of small openings 34 are large enough to allow bodily fluids to interact with the amorphous polymer core 22 otherwise maintained within the constraining jacket 24.
  • the plurality of small openings 34 are small enough to prevent the individual particles of the amorphous polymer core 22 from escaping.
  • the plurality of small openings 34 have an average diameter smaller than the particle size of the individual grains of the amorphous polymer core 22, or about 8x10 "3 inches, although other dimensions are acceptable.
  • the constraining jacket 24 is described as having a weave configuration, any other configuration having a semi-permeable or porous attribute can be used, such as a self-sealing membrane.
  • the preferred woven construction of the constraining jacket 24 also provides a textured outer surface for purchase within the disc space, as described in greater detail below.
  • the constraining jacket 24 prevents the prosthetic spinal disc nucleus 20 from spontaneously dislodging from the disc space. Additionally, the constraining jacket 24 material preferably allows for tissue ingrowth.
  • the prosthetic spinal disc nucleus 20 of the present invention is constructed by selecting the constraining jacket 24 sized to fit within a disc space (described below).
  • the posterior end 28 of the constraining jacket 24 is sewn closed by the posterior closure 32, which is a stitching comprised of the same high-tenacity polymeric material, such as high molecular weight polyethylene, as is used for the constraining jacket 24.
  • the amorphous polymer core 22 (in an unhydrated state) is poured into the constraining jacket 24 at the open, anterior end 26. The anterior end 26 is then closed by the anterior closure 30.
  • the prosthetic spinal disc nucleus 20 is massaged to horizontally orientate the amorphous polymer core 22, partially flattening and narrowing the prosthetic spinal disc nucleus 20 in preparation for implantation.
  • the amorphous polymer core 22 in an unhydrated state
  • the amorphous polymer core 22 due to a flowable attribute in at least a first state, may instead be injected within the constraining jacket 24 by a syringe or small diameter catheter. This approach is described in more detail below.
  • the constraining jacket 24 is sealed at both the anterior end 26 and posterior end 28.
  • the constraining jacket 24 may include a self-sealing mechanism.
  • the self-sealing mechanism may assume a variety of forms, including a normally closed tube extending from the constraining jacket 24 that expands or opens with applied pressure (such as when the amorphous polymer core 22 is forced therethrough).
  • the self-sealing mechanism may be a spiral tube that is normally closed until pressure is applied.
  • the constraining jacket 24 has a generally fixed
  • the volume of the amorphous polymer core 22 in an unhydrated state fills approximately 60% - 80% of the available internal volume of the constraining jacket 24.
  • the percent volumetric filling can be altered, either slightly higher or lower.
  • the volume of the amorphous polymer core 22, where a hydrogel material is used will expand greatly upon hydration.
  • the theoretical volume of the amorphous polymer core 22 in an unconstrained, hydrated state is greater than the internal volume of the constraining j acket 24.
  • the hydrogel material used for the amorphous polymer core 22 can be selected to have a higher or lower swelling behavior.
  • the grains comprising the amorphous polymer core 22 can be coated with a hygroscopic film to increase overall flow by lowering the coefficient of friction between individual grains.
  • the generally fixed maximum volume of the constraining jacket 24 is greater than a volume of the hydrogel material used for the amorphous polymer core 22 in an unhydrated state. Conversely, the generally fixed maximum volume of the constraining jacket 24 is less than the volume of the amorphous polymer core 22 if allowed to hydrate fully without constraint. Thus, because the amorphous polymer core 22 has a natural hydrated volume greater than that of the constraining jacket 24, the constraining jacket 24 will be tight about the amorphous polymer core 22 when hydrated, as described in greater detail below.
  • the volume differential between the constraining jacket 24 and the amorphous polymer core 22 in a hydrated state serves to extend the useful life of the prosthetic spinal disc nucleus 20.
  • the constraining jacket 24 effectively prevents the amorphous polymer core 22 from reaching a natural hydration level. Consequently, the amorphous polymer core 22 will have a constant affinity for imbibing additional fluid.
  • the prosthetic spinal disc nucleus 20 is preferably sized to conform to the approximate length of a sagittal diameter and an approximate height of an adult human disc nucleus cavity.
  • the prosthetic spinal disc nucleus 20 will have, in final form, a length in the range of approximately 10 to 35 millimeters and an outer diameter in the range of approximately 3 to 15 millimeters.
  • the preferred prosthetic spinal disc nucleus 20 is 25 millimeters in length and 10 millimeters in outer diameter. It is realized that not all human disc nucleus cavities are of the same size. Therefore, the prosthetic spinal disc nucleus 20 can be constructed to assume a wide variety of dimensions. The appropriate size of the prosthetic spinal disc nucleus 20 for a particular patient is determined by various diagnostic procedures prior to and during surgery.
  • the properly dimensioned prosthesis is a function of the patient's size and spinal level.
  • the space requirements reflected by any spinal segment, human or animal, are satisfied.
  • the prosthetic spinal disc nucleus 20 is preferably percutaneously implanted into a damaged disc space 60, shown in FIGS. 3-5.
  • the disc space 60 separates two adjacent vertebrae 62, defining opposing endplates (not shown), and includes an anulus 64 and a nucleus cavity 66 (FIG. 5).
  • Implantation is preferably performed via a posterior approach, although it should be understood that an anterior or oblique technique may also be employed. With the posterior method, a unilateral laminotomy in a targeted lamina area 68 may be required. As shown in FIG. 4, a flap 70 is created in the anulus 64, and, if necessary, excess material is removed from the nucleus cavity 66 (FIG. 5) to create room for the prosthetic spinal disc nucleus 20. The appropriate volume of the nucleus cavity 66 is estimated and the prosthetic spinal disc nucleus 20 is selected.
  • an appropriately sized constraining jacket 24 (FIG. 1) is selected and placed through the flap 70. Notably, the opening provided by the flap
  • the constraining jacket 24 is "empty" (i.e., does not initially contain the amorphous polymer core 22) and can therefore be compact for insertion through the opening provided by the flap 70.
  • the constraining jacket 24 is orientated essentially transverse across the disc space 60. With the constraining jacket 24 properly oriented, the amo ⁇ hous polymer core 22 is injected into the constraining jacket 24.
  • Percutaneous injection of the amo ⁇ hous polymer core 22 is achieved through use of a syringe or catheter 72 which is directed to pass through the constraining jacket 24.
  • the preferred hydrogel material of the amo ⁇ hous polymer core 22, in an unhydrated state, is injected into the constraining jacket 24.
  • a variety of methods are available for forcing the amo ⁇ hous polymer core 22 into the constraining jacket 24.
  • pressurized carbon dioxide can be used to force the powder hydrogel into the constraining jacket 24.
  • the amo ⁇ hous polymer core 22 can be forced through the syringe 72 with manually applied pressure.
  • the constraining jacket 24 is preferably configured to essentially be self-sealing such that insertion and removal of the syringe or catheter 72 does not damage or otherwise impart a hole into the constraining jacket 24 large enough to allow particles of the amo ⁇ hous polymer core 22 to escape. Even further, the constraining jacket 24 may be provided with a self-sealing mechanism (described above) to allow efficient introduction and removal of the syringe or catheter 72. While the preferred method has described implantation of a single spinal prosthetic disc nucleus 20 via injection of the amo ⁇ hous polymer core 22, other approaches are equally acceptable.
  • the amo ⁇ hous polymer core 22 and the constraining jacket 24 may be implanted as a single device.
  • the prosthetic spinal disc nucleus 20 may be constructed (i.e., the amo ⁇ hous polymer core 22 placed into the constraining jacket 24) prior to implant into the disc space 60.
  • the prosthetic spinal disc nucleus 20 may be implanted in pairs into the damaged disc space 60 as shown in FIGS. 6-8.
  • the flaps 70a and 70b have a height less than a minor axis dimension of the prosthetic spinal disc nucleus 20.
  • the flaps 70a and 70b have a length of about 12 millimeters and a height of about 6 millimeters for use with a prosthetic body 20 having a minor axis diameter of 7 millimeters.
  • the flaps 70a and 70b need not encompass the entire height of the anulus 64.
  • a pair of flaps 70a and 70b are illustrated and discussed, a single flap may alternatively be used.
  • the vertebrae 62 adjacent the damaged disc space 60 are then slightly separated. This slight separation can be achieved by inserting an inflatable jack (not shown) through one of the flaps 70a or 70b and jacking apart the adjacent vertebrae 62. Once separation sufficient to insert a prosthetic spinal disc nuclei 20 is achieved, the flap 70a or 70b not occupied by the jack has one of the prosthetic spinal disc nucleus 20 inserted via a tapered holding tube. The jack is then deflated and removed, and a second prosthetic spinal disc nucleus 20 is placed through the remaining flap 70a or 70b.
  • each one of the prosthetic spinal disc nuclei 20 is orientated essentially transverse across the disc space 60 as shown in FIG. 8.
  • the amo ⁇ hous polymer core 22 (FIG. 1) of the prosthetic spinal disc nuclei 20 begins to hydrate, imbibing surrounding fluids.
  • saline or similar fluid is injected or flushed into the nucleus cavity 66.
  • the flaps 70a and 70b are sewn into their original position.
  • amo ⁇ hous polymer core 22 will flow to approximately fill the constraining jacket 24 (FIGS. 5 and 8).
  • an internal pressure is created within the constraining jacket 24. More particularly, the hydrogel-based amo ⁇ hous
  • the 16 polymer core 22 generates a swelling pressure as it expands within the constraining jacket 24. Because the constraining jacket is located between adjacent vertebrae 62, the resulting cross-sectional shape of the constraining jacket 24 is a flattened oval. With reference to FIG. 2, then, the amo ⁇ hous polymer core 22 swells to fill this shape, or initial volume, of the constraining jacket 24. Notably, this initial volume is less than the generally fixed maximum volume of the constraining jacket 24 because the constraining jacket 24 is not circular in cross-section, but instead is elliptical.
  • the constraining jacket 24 transitions from the initial volume toward the maximum volume, increasing substantially in height ("x" in FIG. 2).
  • the increase in height of the prosthetic spinal disc nucleus 20 forces the adjacent vertebrae 62 to lift apart and separate to a natural level.
  • the particulate, high surface to volume nature of the amo ⁇ hous polymer core 22 allows for a faster hydration of the prosthetic spinal disc nucleus 20 than if a single, integral core body were provided, since water and body fluids will be quickly distributed throughout the amo ⁇ hous polymer core 22.
  • This rapid hydration promotes a quick expansion of the disc space 60, a rapid rise in disc height with a tightening of the circumferential, ligamentous anulus 64 and an early establishment of a barrier to dislodgment of the prosthetic spinal disc nucleus 20.
  • the preferred powdered hydrogel material of the amo ⁇ hous polymer core 22 permits a small amount of slippage between individual grains and therefore a limited flow of the total core within the constraining jacket 24 as the disc space 60 is wedged during bending motions.
  • the prosthetic spinal disc nucleus 20 is compliant, able to conform to the available internal shape of the nucleus cavity 66 defined by opposing end plates (not shown).
  • the amo ⁇ hous polymer core 22 allows for natural movements between adjacent vertebrae 62 as the viscosity of the amo ⁇ hous polymer core 22 will not change as a function of shear. Even after swelling, the amo ⁇ hous polymer core 22 maintains a degree of deformability, so that the prosthetic spinal disc nucleus 20 will slightly change its shape in response to physiological loads and conditions.
  • the prosthetic spinal disc nucleus 20 functions as an intervertebral spacer and a cushion, and restores the normal fluid pumping action of the disc space 60.
  • the constraining jacket 24 By employing a flexible woven material for the constraining jacket 24, the amo ⁇ hous polymer core 22 is allowed to deform and reform in a controlled fashion in response to physiological loads. As the amo ⁇ hous polymer core 22 imbibes fluid, the constraining jacket 24 has sufficient flexibility to allow the amo ⁇ hous polymer core 22 to expand. However, the strength and flexibility characteristics of the material used for the constraining jacket 24 are such that the general capsule shape of the prosthetic spinal disc nucleus 20 will always be maintained. Further, the constraining jacket 24 prevents undesirable creep of the amo ⁇ hous polymer core 22 due to the substantially inelastic construction.
  • the prosthetic spinal disc nucleus 20 will deform and reform in response to the placement and removal of loads on the disc space 60.
  • the prosthetic spinal disc nucleus 20 flattens in response to placement of physiologic loads on the spine, thus assuming a more flattened shape, and acts as a cushion against various loads placed upon it.
  • the amo ⁇ hous polymer core 22 reforms, as a whole, back to a more circular cross- sectional shape.
  • the constraining jacket 24 directs the amo ⁇ hous polymer core 22 to reform, as a whole, vertically within the nucleus cavity 66. This controlled reformation pushes apart or further separates the adjacent vertebrae 62 (FIGS. 5 and 8), as would a normal nucleus.
  • the prosthetic spinal disc nucleus 20 also restores the natural fluid pumping action of the disc space 60.
  • the hydrated prosthetic spinal disc nucleus 20 occupies a certain percentage, but not all of, the nucleus cavity 66.
  • the prosthetic spinal disc nucleus 20 cushions the vertebral end plates (not shown) and slowly deforms. As a result, the volume within the nucleus cavity 60 decreases.
  • the prosthetic spinal disc nucleus 20 does not occupy the entire nucleus cavity 66, there is room for the prosthetic spinal disc nucleus 20 to deform, and the reduction in volume of the nucleus cavity 66 is allowed to take place as would otherwise occur with a normal nucleus.
  • the amo ⁇ hous polymer core 22 will flatten or deform as a whole, but not decrease in volume in response to the load so that the prosthetic spinal disc nucleus
  • the prosthetic spinal disc nucleus 20 reforms to a more circular cross-sectional shape. This entails an increase in the vertical direction (relative to the spine in an upright position), causing the vertebral end plates (not shown) to separate, creating an increased volume in the nucleus cavity 66. It will be remembered that the amo ⁇ hous polymer core 22 does not increase in volume, but simply reforms. As a result, bodily fluid, containing beneficial nutrients, fills the now- increased volume of the nucleus cavity 66, revitalizing the overall disc space 60. The prosthetic spinal disc nucleus 20 acts in concert with the natural disc space 60 to restore the natural pumping action of the disc space 60.
  • the prosthetic spinal disc nucleus 20 of the present invention independently absorbs the force/pressure placed upon the disc space 60.
  • the anulus 64 is not required to support the force/pressure generated by swelling of the amo ⁇ hous polymer core 22 during hydration.
  • the anulus 64 does not provide any circumferential support to the prosthetic spinal disc nucleus 20.
  • FIGS. 9 and 10 An alternative embodiment of a prosthetic spinal disc nucleus 120 is shown in FIGS. 9 and 10.
  • the prosthetic spinal disc nucleus 120 is highly similar to that previously described, in that it is comprised of an amo ⁇ hous polymer core 122 and a constraining jacket 124.
  • the constraining jacket 124 is identical to the constraining jacket 24 (FIG. 1) previously described, and includes an anterior end 126, a posterior end 128, an anterior closure 130 and a posterior closure 132.
  • the amo ⁇ hous polymer core 122 is defined by a plurality of hydrogel microchips.
  • the plurality of hydrogel microchips 122 are preferably made from the same hydrogel material set forth above. Unlike the previously described amo ⁇ hous
  • FIGS. 11-15 illustrate the manufacturing of the prosthetic spinal disc nucleus 120.
  • a block 140 of hydrogel material is provided.
  • the material making up the block 140 of hydrogel is preferably polyacrylonitrile, although other materials may also be useful.
  • the block 140 of hydrogel material can be cast in any shape.
  • the block 140 of hydrogel material is a cast or extruded rod of polymer approximately one millimeter in diameter. Alternatively, other dimensions may also be useful.
  • the block 140 of hydrogel material is fed into a holding channel (not shown) associated with a milling machine 142, as shown in FIG. 11.
  • the milling machine 142 is a rotating hobbing mill 142 having a number of cutting edges 144.
  • the cutting edges 144 cut the block 140 of hydrogel material, creating the plurality of hydrogel microchips 122. Because the block 140 of hydrogel is preferably amo ⁇ hous and semi-rigid, the cutting edges 144 are able to easily cut the hydrogel material, resulting in a relatively uniform shape.
  • each of the plurality of hydrogel microchips 122 is approximately wedge-shaped.
  • each of the plurality of hydrogel microchips 122 is a crescent-shaped wedge, defined by a convex surface 146 and a concave surface 148.
  • each of a plurality of hydrogel microchips 122 may have a more oval contour, including a slight concavity on one surface 150.
  • each of a plurality of hydrogel microchips 122 can alternatively be an elongated body, having opposing relatively flat surfaces.
  • the plurality of hydrogel microchips 122 can assume any of a number of wedge-shaped configurations. Preferably, however, the particular shape generated facilitates tight stacking between each of the plurality of hydrogel microchips 122.
  • the final shape of each of the plurality of hydrogel microchips 122 is not spherical so that at least a portion of the outer surface is not convex.
  • hydrogel microchips 122 can be closely compacted within the constraining jacket 124 (FIG. 11), as described in greater detail below.
  • the tumbler apparatus 152 includes a drum 154 driven by an obliquely-mounted motor shaft 156. Alternatively, other similar devices may also be used.
  • the plurality of hydrogel microchips 122 are first dry tumbled in the tumbler apparatus 152 so as to slightly dull their outer surface. Thus, the tumbling process abrades and polishes each of the plurality of hydrogel microchips 122, smoothing any sha ⁇ points or edges.
  • any excess material removed during the dry tumbling process is separated from the drum 154, such as by a simple blowing process.
  • a microfilter can be provided to filter the fine particulates from the plurality of hydrogel microchips 122 otherwise maintained in the drum 154.
  • the plurality of hydrogel microchips 122 may be slightly flattened between rotating rollers (not shown) to increase a packing density of the plurality of hydrogel microchips 122.
  • the plurality of hydrogel microchips 122 are tumble-coated with another, softer, low friction formulation of hydrogel.
  • the hydrogel coating may be any suitable, stable, appropriately hygroscopic material.
  • the coating may be a separate polymer having characteristics different from the material of the plurality of hydrogel microchips 122, such as a different shear behavior. Regardless of exact form, the polymer coating facilitates deformation or sliding between individual particles of the plurality of hydrogel microchips 122. As a result, a total mass formed by the plurality of hydrogel microchips 122 exhibits a deformable attribute, and is able to conform to minor variations within a nucleus cavity.
  • a lower friction polyvinyl alcohol or polyacrylonitrile is used as the coating, although other similar materials may also be useful.
  • the coating is formed as a fine, aquatic slurry that is slowly added to the drum 154 while continuously tumbling the plurality of hydrogel microchips 122. The coating material naturally adheres to the plurality of hydrogel
  • each of the plurality of hydrogel microchips 122 individually become thinly coated with the coating material, creating a bonded, smooth surface.
  • the plurality of hydrogel microchips 122 are subjected to warm, filtered air and slowly dehydrated.
  • forced air at a temperature of less than 100C is blown on the plurality of hydrogel microchips 122 while the drum 154 continues to rotate.
  • the polishing, tumble coating and dehydration process results in coarse, free-flowing microchips, each having an approximately wedge shape.
  • adjustments can be made in several parameters in order to achieve the desired static and dynamic behavior of the plurality of hydrogel microchips 122. For example, the viscosity and swelling behavior of the initial block 140 (FIG. 13) of hydrogel; the size and shape of each of the plurality of hydrogel microchips 122; the coefficient of friction and swelling behavior of the coating gel; and the thickness of the coating layer may be altered to achieve desired performance characteristics.
  • the plurality of hydrogel microchips 122 are placed within the constraining jacket 124, as shown in FIG. 16.
  • the constraining jacket 124 is preferably a high molecular weight, polyethylene-woven jacket.
  • the consfraining jacket 124 is closed at the posterior end 128 by the posterior closure 132. Any excess material at the posterior end 128 is removed by a thermal cut, fusing posterior closure 132.
  • the plurality of hydrogel microchips 122 (FIG. 13) are poured into the constraining jacket 124 at the open, anterior end 126. The anterior end 126 is then closed and any excess material is removed from the anterior end 126 by a thermal cut, fusing the anterior closure 130.
  • the preferred prosthetic spinal disc nucleus 20 employs a hydrogel material for the amo ⁇ hous polymer core 22 (FIG. 1). It should be recognized, however, that non-hydrophilic, biocompatible polymers may also be
  • non-hydrophilic polymer that is flowable (or can be maintained flowable) in a first state and cured or non-flowable in a second state can be used.
  • non-hydrophilic encompasses not only hydrophilic materials, but also materials with a slight affinity to water. Thus, any material that cannot imbibe and maintain a significant amount of water relative to an overall volume of the material is considered “non-hydrophilic”.
  • the "flowable" first state can be achieved in a number of different manners, such as by retaining the polymer in a solvent that later is released, use of a catalyst, heating the polymer to a molten state, etc.
  • silicone rubber (RTV) with acetic acid is flowable; once exposed, however, the acid is released and the silicone rubber cures.
  • the resulting prosthetic spinal disc nucleus is basically identical to the preferred prosthetic spinal disc nucleus 20 shown in FIGS. 1 and 2.
  • the substantially inelastic constraining jacket 24 is implanted into the disc space, and the amo ⁇ hous polymer core 22 is percutaneously inserted into the constraining jacket 24, such as by a syringe.
  • the non- hydrophilic polymer used for the amo ⁇ hous polymer core 22 is inserted into the constraining jacket 24 in the first, flowable state, filling an initial volume of the • constraining jacket 24 (which is less than the generally fixed maximum volume).
  • the constraining jacket 24 transitions from the initial volume to the generally fixed maximum volume, increasing substantially in height ("x" in FIG. 2). In other words, the constraining jacket transitions from a flattened, oval shape to a more circular cross-section.
  • This structural characteristic of the constraining jacket 24 is identical to the previous embodiments and results in necessary spacing between adjacent vertebrae.
  • the amo ⁇ hous polymer core 22 cures, preferably remaining somewhat compliant.
  • the prosthetic spinal disc nucleus 20 functions identically to the previous embodiments, acting in concert with the disc space to pump fluids into and out of the nucleus cavity.
  • the prosthetic spinal disc nucleus of the present invention a) restores the height of the damaged disc space; b) restores and tightens the natural anulus to stop further degeneration and permit its healing; c) restores the normal load-unload cycling and thus flushes out toxic by-products, bringing in fresh nutrients to the disc space; d) allows a near-normal range of motion; e) relieves the movement-induced discogenic pain of the vertebral segment; and f) allows the use of a minimal, posterior surgical procedure that provides both cost and medical benefits.
  • the prosthetic spinal disc nucleus of the present invention has the ability to elevate the disc space from the inside, as does the normal, highly hygroscopic nucleus.
  • the prosthetic spinal disc nucleus of the present invention has the unique ability to conform to contours of the available internal nucleus cavity. Further, the prosthetic spinal disc nucleus will exhibit shear behavior under load, imitating the normal, constrained rheology of the natural disc nucleus. Finally, hospital inventory costs are greatly reduced in that the final size of the prosthetic spinal disc nucleus need not be determined until actual surgery. The surgeon then simply chooses an appropriately sized constraining jacket and subsequently inserts a sufficient amount of the amo ⁇ hous polymer core.

Abstract

A capsule-shaped prosthetic spinal disc nucleus (20) for implantation into a human intradiscal space (60), made of a substantially inelastic constraining jacket (24) surrounding an amorphous polymer core (22). The constraining jacket (24) has a generally fixed maximum volume and defines a height. The amorphous polymer core (22) fills an initial volume of the constraining jacket (24) and develops an internal pressure. In response to the internal pressure, the constraining jacket (24) transitions toward the maximum volume, increasing substantially in height.

Description

PERCUTANEOUS PROSTHETIC SPINAL DISC NUCLEUS AND METHOD OF MANUFACTURE
Cross-Reference to Co-Pending Application This is a continuation-in-part of co-pending application Serial No. 08/870,866 filed on June 6, 1997.
BACKGROUND OF THE INVENTION
The present invention relates to a prosthetic spinal disc nucleus. More particularly, it relates to a percutaneously implantable, capsule-shaped intradiscal prosthesis and a method of manufacture therefor.
The vertebral spine is the axis of the skeleton upon which all of the body parts "hang". In humans, the normal spine has seven cervical, twelve thoracic and five lumbar segments. The lumbar segments sit upon the sacrum, which then attaches to the pelvis, in turn supported by the hip and leg bones. The bony vertebral bodies of the spine are separated by intervertebral discs, which act as joints, but allow known degrees of flexion, extension, lateral bending and axial rotation.
The typical vertebra has a thick interior bone mass called the vertebral body, with a neural (vertebral) arch that arises from a posterior surface of the vertebral body. Each narrow arch combines with the posterior surface of the vertebral body and encloses a vertebral foramen. The vertebral foramina of adjacent vertebrae are aligned to form a vertebral canal, through which the spinal sac, cord and nerve rootlets pass. The portion of the neural arch that extends posteriorly and acts to protect a posterior side of the spinal cord is known as the lamina. Projecting from the posterior region of the neural arch is a spinous process. The centra of adjacent vertebrae are supported by the intervertebral disc. The intervertebral disc primarily serves as a mechanical cushion between the vertebral bones, permitting controlled motions within vertebral segments of the axial skeleton. The normal disc is a unique, mixed structure, comprised of three component tissues: The nucleus pulposus ("nucleus"), the anulus fibrosus ("anulus"), and two opposing vertebral end plates. The two vertebral end plates are each composed of thin cartilage overlying a thin layer of hard, cortical bone which attaches to the spongy, richly vascular, cancellous bone of the vertebral body. The end plates thus serve to attach adjacent vertebrae to the disc. In other words, a transitional zone is created by the end plates between the malleable disc and the bony vertebrae.
The anulus of the disc is a tough, outer fibrous ring that binds together adjacent vertebrae. This fibrous portion, which is much like a laminated automobile tire, is generally about 10 to 15 millimeters in height and about 15 to 20 millimeters in thickness. The fibers of the anulus consist of 15 to 20 overlapping multiple plies, and are inserted into the superior and inferior vertebral bodies at roughly a 30 angle in both directions. This configuration particularly resists torsion, as about half of the angulated fibers will tighten when the vertebrae rotate in either direction, relative to each other. The laminated plies are less firmly attached to each other.
Immersed within the anulus, positioned much like the liquid core of a golf ball, is the nucleus. The healthy nucleus is largely a gel-like substance having a high water content, and similar to air in a tire, serves to keep the anulus tight yet flexible. The nucleus-gel moves slightly within the anulus when force is exerted on the adjacent vertebrae with bending, lifting, etc.
The nucleus and the inner portion of the anulus have no direct blood supply. In fact, the principal nutritional source for the central disc arises from circulation within the vertebral body. Microscopic, villous-like fmgerlings of the nuclear and anular tissue penetrate the vertebral end plates and allow fluids to pass from the blood across the cell membrane of the fmgerlings and then inward to the nuclear tissue. These fluids are primarily body water and the smallest molecular weight nutrients and electrolytes.
The natural physiology of the nucleus promotes these fluids being brought into and released from the nucleus by cyclic loading. When fluid is forced out of the nucleus, it passes again through the end plates and then back into the richly vascular vertebral bodies. The cyclic loading amounts to daily variations in applied pressure on the vertebral column (e.g., body weight and muscle pull) causing the nucleus to expel fluids, followed by periods of relaxation and rest, resulting in fluid absorption or swelling by the nucleus. Thus, the nucleus changes volume under loaded and non-loaded conditions. Further, the resulting tightening and loosening effect on the anulus stimulates normal anulus collagen fibers to remain healthy or to regenerate when torn, a process found in all normal ligaments related to body joints. Notably, the ability of the nucleus to release and imbibe fluids allows the spine to alter its height and flexibility through periods of loading or relaxation. Normal loading cycling is thus an effective nucleus and inner anulus tissue fluid pump, not only bringing in fresh nutrients, but perhaps more importantly, removing the accumulated, potentially autotoxic by-products of metabolism.
The spinal disc may be displaced or damaged due to trauma or a disease process. A disc herniation occurs when the anulus fibers are weakened or torn and the inner tissue of the nucleus becomes permanently bulged, distended, or extruded out of its normal, internal anular confines. The mass of a herniated or "slipped" nucleus can compress a spinal nerve, resulting in leg pain, loss of muscle control, or even paralysis. Alternatively, with discal degeneration, the nucleus loses its water binding ability and deflates, as though the air had been let out of a tire. Subsequently, the height of the nucleus decreases, causing the anulus to buckle in areas where the laminated plies are loosely bonded. As these overlapping laminated plies of the anulus begin to buckle and separate, either circumferential or radial anular tears may occur, which may contribute to persistent and disabling back pain. Adjacent, ancillary spinal facet joints will also be forced into an overriding position, which may create additional back pain.
Whenever the nucleus tissue is herniated or removed by surgery, the disc space will narrow and may lose much of its normal stability. In many cases, to alleviate pain from degenerated or herniated discs, the nucleus is removed and the two adjacent vertebrae surgically fused together. While this treatment alleviates the pain, all discal motion is lost in the fused segment. Ultimately, this procedure places greater stresses on the discs adjacent to the fused segment as they compensate for the lack of motion, perhaps leading to premature degeneration of those adjacent discs. A more desirable solution entails replacing in part or as a whole the damaged nucleus with a suitable prosthesis having the ability to complement the normal height and motion of the disc while stimulating the natural disc physiology. Restoring the nutrition-flushing cycle of a natural disc is important for a prosthetic spinal disc nucleus to be successful. Vascular circulation and nerve supply to the disc is limited to the outer layers of the anulus, never penetrating more than a few millimeters, or about five of the anular plies. Most of the nutrition for the inner anulus and nucleus is provided by diffusion through the end plates of the vertebral bodies and by the important pumping action between the partially loaded and fully loaded conditions of the disc. If the nutritional cycle is impeded, a variety of degenerative changes may occur. Nutrition to the inner disc slowly ceases, resulting in intradiscal build-up of acids and autotoxins, and other changes. This is followed by nuclear and anular fiber degeneration, shrinkage of the nucleus, segmental laxity, spur formation, disc space collapse and perhaps spontaneous fusion. Additionally, significantly disabling back pain may develop.
As an alternative to vertebral fusion, various prosthetic discs have been developed. The first prostheses embodied a wide variety of ideas, such as ball bearings, springs, metal spikes and other perceived aids. These prosthetic discs were designed to replace the entire intervertebral disc space and were large and rigid. Beyond the questionable applicability of these devices is the inherent difficulties encountered during implantation. Due to their size and inflexibility, these devices required an anterior implantation approach as the barriers presented by the lamina and, more importantly, the spinal cord and nerve rootlets during posterior implantation could not be avoided. Recently, smaller and more flexible prosthetic nucleus devices have been developed. With the reduction in prosthesis size, the ability to work around the spinal cord and nerve rootlets during posterior implantation has become possible. One such application utilizes a hydrogel-based material as a replacement for the natural nucleus. For example, Bao et al., U.S. Patent No. 5,047,055, discloses a prosthetic nucleus for a vertebral disc made of a hydrogel material. Prior to implant, the hydrogel material is implanted into the intradiscal space in a dehydrated state. The hydrogel material then hydrates to a shape conforming to the natural nucleus. Similarly, Bao et al., U.S. Patent No. 5,192,326, describes a prosthetic nucleus comprised of a solid hydrogel core or a multiplicity of hydrogel beads surrounded by a membrane. Once again, this prosthesis is implanted into the disc space in a dehydrated state, subsequently hydrating to a shape conforming to the natural nucleus.
While posterior implantation is available with the devices described in the two Bao patents, several drawbacks exist. For example, because the prosthesis is purposefully designed to match the shape of the nucleus cavity, accurate orientation of the prosthetic disc within the nucleus cavity prior to hydration is difficult to ascertain. Additionally, the Bao devices rely solely upon the natural anulus to constrain expansion of the hydrogel core. Obviously, with most applications, the anulus is already damaged, and any additional forces placed upon the anulus by the prosthesis may impede healing and even cause further deterioration. Similarly, implantation of the Bao devices inherently requires imparting an opening through the anulus. Because the Bao devices rely exclusively on the anulus for expansion constraint, there is a distinct possibility that the prosthesis may migrate out from the nucleus cavity through the hole in the anulus. Further, the hydrogel bead-based prosthesis requires molding hydrogel beads to a size of 40-120 m. Beyond the costs associated with creating an appropriately sized mold, the spherical-shaped beads inherently result in undesirable spacing between individual beads. In other words, upon hydration, the hydrogel beads are not compactly stacked, resulting in a prosthesis that may not provide necessary intradiscal support. Degenerated, painfully disabling interspinal discs are a major economic and social problem for patients, their families, employers and the public at large. Any significant means to correct these conditions without further destruction or fusion of the disc may therefore serve an important role. Other means to replace the function of a degenerated disc have major problems such as complex surgical procedures, unproven efficacy, place unnecessary and possibly destructive forces on an already damaged anulus, etc. Therefore, a substantial need exists for an easily-implantable prosthetic spinal disc nucleus that restores the size, load-bearing ability and pumping action of a normal disc while minimizing any additional trauma to the disc space. SUMMARY OF THE INVENTION The present invention provides an elongated prosthetic spinal disc nucleus for implantation deep inside a nucleus cavity of a human disc space and a method of manufacturing such a prosthesis. The nucleus cavity is defined by an opposing pair of vertebral bodies, forming opposing endplates, and an anulus. The prosthesis is comprised of a substantially inelastic constraining jacket maintaining an amorphous polymer core.
The constraining jacket is preferably flexible but inelastic, having a generally fixed maximum volume that is less than a volume of the nucleus cavity. The maximum volume of the constraining jacket is determined by a generally fixed circumference and length. Further, the constraining jacket defines a height corresponding to a plane substantially perpendicular to the opposing endplates.
The amorphous polymer core is flowable in at least a first state. The amorphous polymer core is disposed within the constraining jacket and is configured such that upon insertion, the amorphous polymer core fills an initial volume of the constraining jacket and creates an internal pressure within the constraining jacket. The constraining jacket, in turn, is configured to transition from the initial volume toward the maximum volume, increasing substantially in height in response to the internal pressure. In one preferred embodiment, the amorphous polymer core is a hydrogel configured to expand from an unhydrated state to a hydrated state. With this embodiment, the maximum volume of the constraining jacket is greater than a volume of the hydrogel in the unhydrated state, but less than a theoretical, unconstrained volume of the hydrogel in the hydrated state. The internal pressure within the constraining jacket is a swelling pressure of the hydrogel transitioning from the unhydrated state to the hydrated state.
The preferred method of manufacturing a prosthetic spinal disc nucleus in accordance with the present invention includes providing a substantially inelastic constraining jacket and an amorphous polymer core that is flowable in at least a first state. The constraining jacket has a generally fixed maximum volume determined by a fixed circumference and length and defines a height corresponding to a transverse plane of the nucleus cavity. The maximum volume of the constraining jacket is less than a volume of the nucleus cavity.
The amorphous polymer core, in a flowable state, is inserted into the constraining jacket and fills an initial volume of the consfraiiring jacket. An internal pressure is generated within the constraining jacket. The constraining jacket transitions from the initial volume toward the maximum volume and increases substantially in height in response to the internal pressure.
One preferred application includes implanting a properly sized constraining jacket into a nucleus cavity of a damaged disc space. The amorphous polymer core, in a flowable state, is then inserted into the constraining jacket, via a syringe or small diameter catheter. This insertion preferably occurs percutaneously. In an alternative embodiment, the amorphous polymer core is placed within the constraining jacket prior to implant.
Following implant, the prosthetic spinal disc nucleus of the present invention reestablishes near-normal disc height and near-normal anulus position and function. Additionally, by utilizing an amorphous polymer core, the prosthetic spinal disc nucleus is compliant such that the prosthesis will conform to the available internal shape of the nucleus cavity, although it does not encompass the entire cavity. Finally, the constraining jacket serves to direct and constrain the amorphous polymer core, minimizing transverse forces on an interior of the anulus.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a perspective view of a prosthetic spinal disc nucleus, including a cut-away view showing a portion of a core, in accordance with the present invention;
FIG. 2 is a front sectional view of the prosthetic spinal disc nucleus along the line 2-2 of FIG. 1;
FIG. 3 is a posterior view of a spinal segment including a degenerated discal area; FIG. 4 is a posterior view of the spinal segment of FIG. 3 showing a flap that has been cut through an anulus; FIG. 5 is a top, sectional view of a human disc space having a prosthetic spinal disc nucleus in accordance with the present invention implanted;
FIG. 6 is a posterior view of a spinal segment including a degenerated discal area; FIG. 7 is a posterior view of the spinal segment of FIG. 6 showing two flaps that have been cut through an anulus;
FIG. 8 is a top, sectional view of a human disc space having two prosthetic spinal disc nuclei implanted by an alternative method in accordance with the present invention; FIG. 9 is a perspective view of an alternative embodiment of a prosthetic spinal disc nucleus, including a cut-away view showing a portion of a core, in accordance with the present invention;
FIG. 10 is a front sectional view of the prosthetic spinal disc nucleus of FIG. 9 along the line 10-10; and FIGS. 11-15 illustrate steps of fabricating the alternative prosthetic spinal disc nucleus of FIG. 9 in accordance with the present invention.
DETAILED DESCRIPTION OF THE INVENTION A preferred embodiment of a prosthetic spinal disc nucleus 20 is shown in FIG. 1. The prosthetic spinal disc nucleus 20 is a capsule-shaped body comprised of an amorphous polymer core 22 and a constraining jacket 24. The constraining jacket 24 is defined by an anterior end 26 and a posterior end 28, and is secured around the amorphous polymer core 22 by an anterior closure 30 located at the anterior end 26 and a posterior closure 32 located at the posterior end 28. Various components of the prosthetic spinal disc nucleus 20 are described in greater detail below. Generally speaking, however, the amorphous polymer core 22 is preferably configured to be flowable in at least a first state. The amorphous polymer core 22 is inserted into the constraining jacket 24, generating an internal pressure. The constraining jacket 24 is configured to be flexible, but substantially inelastic such that the prosthetic spinal disc nucleus 20 increases in a desired direction in response to the internal pressure. A. Amorphous Polymer Core 22 As A Hydrogel In a preferred embodiment, the amorphous polymer core 22 is a hydrogel configured to imbibe fluids, expanding from an unhydrated state to a hydrated state. In this regard, the hydrogel material is preferably formulated as a mixture of hydrogel polyacrylonitrile. In particular, acrylamide and acrylonitrile (block co- polymer) are used. Alternatively, the hydrogel material used for the amorphous polymer core 22 can be any hydrophilic acrylate derivative with a unique multiblock copolymer structure or any other hydrogel material having the ability to deform and reform in a desired fashion in response to placement and removal of loads. Even further, a biologically-safe polymer or elastomer that can imbibe fluids while maintaining its structure under various stresses is acceptable. For example, the amorphous polymer core 22 can be formulated as a mixture of polyvinyl alcohol and water. In one preferred embodiment, the hydrogel material used for the amorphous polymer core 22 is manufactured under the trade name HYP AN® by Hymedix International, Inc. of Dayton, NJ.
In one preferred embodiment, the hydrogel material of the amorphous polymer core 22 is in a powder form. In other words, the amorphous polymer core 22 preferably consists of a plurality of fine, irregularly shaped grains of hydrogel material. The grains are non-spherical. With this configuration, each of the grains of hydrogel material has a width on the order of 8xl0"3 inches. Acceptable powder hydrogel material is available, for example, under the tradename HYP AN® from Hymedix International, Inc. of Dayton, NJ. The hydrogel powder may be used as supplied by the manufacturer, or may be processed to generally orientate the shape of the individual grains. In a preferred embodiment, the individual grains have a flat side, and are defined by a height less than a length and a width. For example, each of the flattened hydrogel powder grains will preferably have a height, length and width aspect ratio of approximately 1:5:5. With this configuration, the flattened hydrogel powder grains will lie against one another when compacted, and have a tendency to slide. The shape of individual grains of the amorphous polymer core 22 may be further controlled, as described in greater detail below.
While each grain of hydrogel material of the amorphous polymer core 22 does have a discernable shape, the overall amorphous polymer core 22 does not. Therefore, the amorphous polymer core 22 has a fluid-like attribute such that in at least one state the amorphous polymer core 22 will flow. For example, in the preferred embodiment wherein the amorphous polymer core 22 is a powdered hydrogel, the individual grains are relatively small such that the powder as a whole "flows". This flowable attribute can be enhanced by coating the individual grains with a low friction material, such as polyvinyl alcohol or polyacrylonitrite.
While the amorphous polymer core 22 has been preferably described as consisting of a dry, hydrogel powder, other forms are acceptable. For example, the amorphous polymer core 22 may consist of a hydrogel powder, as described above, suspended in a viscous liquid. In one preferred embodiment, the viscous liquid is glycerine, although other similar fluid carriers able to suspend hydrogel powder can be used. Even further, the amorphous polymer core 22 may be a fluid hydrogel, consisting of dry hydrogel powder, as described above, dissolved in a solvent, such as Dimethyl Sulfoxide (DMSO). Other solvents able to keep the hydrogel polymer chains mobile are also available. The resulting fluid hydrogel is non-thixotropic. Prior to exposure to water (such as in a disc space), the fluid hydrogel flows. However, upon contact with water, the solvent is replaced by water, causing the fluid hydrogel to permanently congeal or solidify. Thus, upon hydration, the fluid hydrogel will fuse into solid form. It should be understood that the solid form of the fluid hydrogel will still have a conformability characteristic, such that the amorphous polymer core 22 will deform slightly in response to various loads.
Regardless of exact form, where a hydrogel material is used, the amorphous polymer core 22 expands from a dehydrated state (prior to implant) to a hydrated state (following implant). In the dehydrated state, the amorphous polymer core 22 flows, such that it can be poured or injected into the constraining jacket 24, as described below.
B. Constraining Jacket 24
Completely surrounding the amorphous polymer core 22 is the constraining jacket 24. The constraining jacket 24 is preferably a capsule-shaped tube made of a tightly-woven, high molecular weight, high tenacity polymeric fabric. In a preferred embodiment, high molecular weight polyethylene is used as the weave material for the constraining jacket 24. However, polyester or any other high
10 molecular weight, high tenacity polymeric material can be employed, and carbon fiber yarns, ceramic fibers, metallic fibers, etc., are also acceptable. While the constraining jacket 24 is itself flexible, the material comprising the constraining jacket 24 is not. In other words, the material making up the constraining jacket 24 has virtually no stretch.
The constraining jacket 24 is preferably made of fibers that have been highly orientated along their length. As a result, the constraining jacket 24 material, while flexible, has little elasticity or stretch and a generally fixed maximum volume.
The maximum volume of the constraining jacket 24 is defined by a generally fixed length and circumference. Additionally, with reference to FIG. 2, the constraining jacket 24 defines a height and a width. The height of the constraining jacket 24 corresponds to a transverse plane of a nucleus cavity (not shown) and is represented by the "x" plane in FIG. 2. Conversely, the width of the constraining jacket 24 corresponds to the sagittal plane of the nucleus cavity and is represented by the "y" plane in FIG. 2.
The preferred woven construction of the constraining jacket 24 creates a plurality of small openings 34, as shown in FIG. 2. The plurality of small openings 34 are large enough to allow bodily fluids to interact with the amorphous polymer core 22 otherwise maintained within the constraining jacket 24. However, the plurality of small openings 34 are small enough to prevent the individual particles of the amorphous polymer core 22 from escaping. Preferably, the plurality of small openings 34 have an average diameter smaller than the particle size of the individual grains of the amorphous polymer core 22, or about 8x10"3 inches, although other dimensions are acceptable. While the constraining jacket 24 is described as having a weave configuration, any other configuration having a semi-permeable or porous attribute can be used, such as a self-sealing membrane.
The preferred woven construction of the constraining jacket 24 also provides a textured outer surface for purchase within the disc space, as described in greater detail below. Thus, the constraining jacket 24 prevents the prosthetic spinal disc nucleus 20 from spontaneously dislodging from the disc space. Additionally, the constraining jacket 24 material preferably allows for tissue ingrowth.
11 C. Construction of Prosthetic Spinal Disc Nucleus 20 With Hydrogel Material
In one embodiment, the prosthetic spinal disc nucleus 20 of the present invention is constructed by selecting the constraining jacket 24 sized to fit within a disc space (described below). The posterior end 28 of the constraining jacket 24 is sewn closed by the posterior closure 32, which is a stitching comprised of the same high-tenacity polymeric material, such as high molecular weight polyethylene, as is used for the constraining jacket 24. The amorphous polymer core 22 (in an unhydrated state) is poured into the constraining jacket 24 at the open, anterior end 26. The anterior end 26 is then closed by the anterior closure 30. Following closure of the anterior end 26 of the constraining jacket 24, the prosthetic spinal disc nucleus 20 is massaged to horizontally orientate the amorphous polymer core 22, partially flattening and narrowing the prosthetic spinal disc nucleus 20 in preparation for implantation. As an alternative to pouring the amorphous polymer core 22 (in an unhydrated state) into the constraining jacket 24, the amorphous polymer core 22, due to a flowable attribute in at least a first state, may instead be injected within the constraining jacket 24 by a syringe or small diameter catheter. This approach is described in more detail below. Generally speaking, however, the constraining jacket 24 is sealed at both the anterior end 26 and posterior end 28. A syringe or small diameter catheter is passed through an outer wall of the constraining jacket 24 and an appropriate volume of the amorphous polymer core 22 is injected. To facilitate injection, the constraining jacket 24 may include a self-sealing mechanism. The self-sealing mechanism may assume a variety of forms, including a normally closed tube extending from the constraining jacket 24 that expands or opens with applied pressure (such as when the amorphous polymer core 22 is forced therethrough). Alternatively, the self-sealing mechanism may be a spiral tube that is normally closed until pressure is applied.
Regardless of whether the amorphous polymer core 22 is placed into the constraining jacket 24 before or after implant, an important concern is the actual amount or total volume of the amorphous polymer core 22 relative to the volume of the constraining jacket 24. The constraining jacket 24 has a generally fixed
12 maximum volume. In a preferred embodiment, the volume of the amorphous polymer core 22 in an unhydrated state fills approximately 60% - 80% of the available internal volume of the constraining jacket 24. Alternatively, the percent volumetric filling can be altered, either slightly higher or lower. As described in greater detail below, the volume of the amorphous polymer core 22, where a hydrogel material is used, will expand greatly upon hydration. Thus, while the volume of amorphous polymer core 22 in the dehydrated state is less than the internal volume of the constraining jacket 24, the theoretical volume of the amorphous polymer core 22 in an unconstrained, hydrated state is greater than the internal volume of the constraining j acket 24.
In addition to varying the volume of the amorphous polymer core 22 placed within the constraining jacket 24, other adjustments can be made to better meet the needs of a particular disc space. For example, the hydrogel material used for the amorphous polymer core 22 can be selected to have a higher or lower swelling behavior. Alternatively, the grains comprising the amorphous polymer core 22 can be coated with a hygroscopic film to increase overall flow by lowering the coefficient of friction between individual grains.
As described above, the generally fixed maximum volume of the constraining jacket 24 is greater than a volume of the hydrogel material used for the amorphous polymer core 22 in an unhydrated state. Conversely, the generally fixed maximum volume of the constraining jacket 24 is less than the volume of the amorphous polymer core 22 if allowed to hydrate fully without constraint. Thus, because the amorphous polymer core 22 has a natural hydrated volume greater than that of the constraining jacket 24, the constraining jacket 24 will be tight about the amorphous polymer core 22 when hydrated, as described in greater detail below.
In this manner, the volume differential between the constraining jacket 24 and the amorphous polymer core 22 in a hydrated state serves to extend the useful life of the prosthetic spinal disc nucleus 20. In particular, the constraining jacket 24 effectively prevents the amorphous polymer core 22 from reaching a natural hydration level. Consequently, the amorphous polymer core 22 will have a constant affinity for imbibing additional fluid.
13 In final form, the prosthetic spinal disc nucleus 20 is preferably sized to conform to the approximate length of a sagittal diameter and an approximate height of an adult human disc nucleus cavity. For example, in one preferred embodiment, the prosthetic spinal disc nucleus 20 will have, in final form, a length in the range of approximately 10 to 35 millimeters and an outer diameter in the range of approximately 3 to 15 millimeters. The preferred prosthetic spinal disc nucleus 20 is 25 millimeters in length and 10 millimeters in outer diameter. It is realized that not all human disc nucleus cavities are of the same size. Therefore, the prosthetic spinal disc nucleus 20 can be constructed to assume a wide variety of dimensions. The appropriate size of the prosthetic spinal disc nucleus 20 for a particular patient is determined by various diagnostic procedures prior to and during surgery.
Basically, the properly dimensioned prosthesis is a function of the patient's size and spinal level. By providing a different prosthetic spinal disc nucleus 20 with varying dimensions, the space requirements reflected by any spinal segment, human or animal, are satisfied.
D. Implantation and Function of The Prosthetic Spinal Disc Nucleus 20
With Hydrogel Material In one preferred embodiment, the prosthetic spinal disc nucleus 20 is preferably percutaneously implanted into a damaged disc space 60, shown in FIGS. 3-5. The disc space 60 separates two adjacent vertebrae 62, defining opposing endplates (not shown), and includes an anulus 64 and a nucleus cavity 66 (FIG. 5).
Implantation is preferably performed via a posterior approach, although it should be understood that an anterior or oblique technique may also be employed. With the posterior method, a unilateral laminotomy in a targeted lamina area 68 may be required. As shown in FIG. 4, a flap 70 is created in the anulus 64, and, if necessary, excess material is removed from the nucleus cavity 66 (FIG. 5) to create room for the prosthetic spinal disc nucleus 20. The appropriate volume of the nucleus cavity 66 is estimated and the prosthetic spinal disc nucleus 20 is selected.
More particularly, the surgeon evaluates the disc space 60 in terms of pressure, volume, degree of disc distention or other visual clues. With this information in mind, an appropriately sized constraining jacket 24 (FIG. 1) is selected and placed through the flap 70. Notably, the opening provided by the flap
14 70 can be very small because the constraining jacket 24 is "empty" (i.e., does not initially contain the amorphous polymer core 22) and can therefore be compact for insertion through the opening provided by the flap 70. As shown in FIG. 5, the constraining jacket 24 is orientated essentially transverse across the disc space 60. With the constraining jacket 24 properly oriented, the amoφhous polymer core 22 is injected into the constraining jacket 24.
Percutaneous injection of the amoφhous polymer core 22 is achieved through use of a syringe or catheter 72 which is directed to pass through the constraining jacket 24. The preferred hydrogel material of the amoφhous polymer core 22, in an unhydrated state, is injected into the constraining jacket 24. A variety of methods are available for forcing the amoφhous polymer core 22 into the constraining jacket 24. For example, where the amoφhous polymer core 22 is comprised of a powder hydrogel material, pressurized carbon dioxide can be used to force the powder hydrogel into the constraining jacket 24. Alternatively, with hydrogel powder suspended in a liquid, or a fluid hydrogel, the amoφhous polymer core 22 can be forced through the syringe 72 with manually applied pressure.
Once the amoφhous polymer core 22 has been deposited, the syringe or catheter 72 is removed. In this regard, the constraining jacket 24 is preferably configured to essentially be self-sealing such that insertion and removal of the syringe or catheter 72 does not damage or otherwise impart a hole into the constraining jacket 24 large enough to allow particles of the amoφhous polymer core 22 to escape. Even further, the constraining jacket 24 may be provided with a self-sealing mechanism (described above) to allow efficient introduction and removal of the syringe or catheter 72. While the preferred method has described implantation of a single spinal prosthetic disc nucleus 20 via injection of the amoφhous polymer core 22, other approaches are equally acceptable. For example, the amoφhous polymer core 22 and the constraining jacket 24 may be implanted as a single device. In other words, the prosthetic spinal disc nucleus 20 may be constructed (i.e., the amoφhous polymer core 22 placed into the constraining jacket 24) prior to implant into the disc space 60. Even further, the prosthetic spinal disc nucleus 20 may be implanted in pairs into the damaged disc space 60 as shown in FIGS. 6-8. With this approach,
15 a pair of flaps 70a and 70b (FIG. 7) are created in the anulus 64 to provide for passage for two of the prosthetic spinal disc nuclei 20.
The flaps 70a and 70b have a height less than a minor axis dimension of the prosthetic spinal disc nucleus 20. In a preferred embodiment, the flaps 70a and 70b have a length of about 12 millimeters and a height of about 6 millimeters for use with a prosthetic body 20 having a minor axis diameter of 7 millimeters. Importantly, because the prosthetic spinal disc nucleus 20 can be massaged to a flattened shape, the flaps 70a and 70b need not encompass the entire height of the anulus 64. Although in this example, a pair of flaps 70a and 70b are illustrated and discussed, a single flap may alternatively be used.
The vertebrae 62 adjacent the damaged disc space 60 are then slightly separated. This slight separation can be achieved by inserting an inflatable jack (not shown) through one of the flaps 70a or 70b and jacking apart the adjacent vertebrae 62. Once separation sufficient to insert a prosthetic spinal disc nuclei 20 is achieved, the flap 70a or 70b not occupied by the jack has one of the prosthetic spinal disc nucleus 20 inserted via a tapered holding tube. The jack is then deflated and removed, and a second prosthetic spinal disc nucleus 20 is placed through the remaining flap 70a or 70b.
With the alternative implantation approach, each one of the prosthetic spinal disc nuclei 20 is orientated essentially transverse across the disc space 60 as shown in FIG. 8. Once implanted, the amoφhous polymer core 22 (FIG. 1) of the prosthetic spinal disc nuclei 20 begins to hydrate, imbibing surrounding fluids. To promote an increase in the rate of hydration, saline or similar fluid is injected or flushed into the nucleus cavity 66. Finally, the flaps 70a and 70b are sewn into their original position.
Regardless of the number of prosthetic spinal disc nuclei 20 implanted or whether the amoφhous polymer core 22 is placed within the constraining jacket 24 before or after the constraining jacket 24 is positioned within the disc space 60, upon insertion the amoφhous polymer core 22 will flow to approximately fill the constraining jacket 24 (FIGS. 5 and 8). As the hydrogel hydrates, or transitions from the unhydrated state to the hydrated state, an internal pressure is created within the constraining jacket 24. More particularly, the hydrogel-based amoφhous
16 polymer core 22 generates a swelling pressure as it expands within the constraining jacket 24. Because the constraining jacket is located between adjacent vertebrae 62, the resulting cross-sectional shape of the constraining jacket 24 is a flattened oval. With reference to FIG. 2, then, the amoφhous polymer core 22 swells to fill this shape, or initial volume, of the constraining jacket 24. Notably, this initial volume is less than the generally fixed maximum volume of the constraining jacket 24 because the constraining jacket 24 is not circular in cross-section, but instead is elliptical. From this point, as the amoφhous polymer core 22 continues to swell (and generate the internal pressure), the constraining jacket 24 transitions from the initial volume toward the maximum volume, increasing substantially in height ("x" in FIG. 2). The increase in height of the prosthetic spinal disc nucleus 20, in turn, forces the adjacent vertebrae 62 to lift apart and separate to a natural level.
The particulate, high surface to volume nature of the amoφhous polymer core 22 allows for a faster hydration of the prosthetic spinal disc nucleus 20 than if a single, integral core body were provided, since water and body fluids will be quickly distributed throughout the amoφhous polymer core 22. This rapid hydration promotes a quick expansion of the disc space 60, a rapid rise in disc height with a tightening of the circumferential, ligamentous anulus 64 and an early establishment of a barrier to dislodgment of the prosthetic spinal disc nucleus 20. Following hydration, the preferred powdered hydrogel material of the amoφhous polymer core 22 permits a small amount of slippage between individual grains and therefore a limited flow of the total core within the constraining jacket 24 as the disc space 60 is wedged during bending motions. Due to the unique design of the amoφhous polymer core 22, the prosthetic spinal disc nucleus 20 is compliant, able to conform to the available internal shape of the nucleus cavity 66 defined by opposing end plates (not shown). Thus, the amoφhous polymer core 22 allows for natural movements between adjacent vertebrae 62 as the viscosity of the amoφhous polymer core 22 will not change as a function of shear. Even after swelling, the amoφhous polymer core 22 maintains a degree of deformability, so that the prosthetic spinal disc nucleus 20 will slightly change its shape in response to physiological loads and conditions.
17 Following implantation, the prosthetic spinal disc nucleus 20 functions as an intervertebral spacer and a cushion, and restores the normal fluid pumping action of the disc space 60. By employing a flexible woven material for the constraining jacket 24, the amoφhous polymer core 22 is allowed to deform and reform in a controlled fashion in response to physiological loads. As the amoφhous polymer core 22 imbibes fluid, the constraining jacket 24 has sufficient flexibility to allow the amoφhous polymer core 22 to expand. However, the strength and flexibility characteristics of the material used for the constraining jacket 24 are such that the general capsule shape of the prosthetic spinal disc nucleus 20 will always be maintained. Further, the constraining jacket 24 prevents undesirable creep of the amoφhous polymer core 22 due to the substantially inelastic construction.
The prosthetic spinal disc nucleus 20 will deform and reform in response to the placement and removal of loads on the disc space 60. The prosthetic spinal disc nucleus 20 flattens in response to placement of physiologic loads on the spine, thus assuming a more flattened shape, and acts as a cushion against various loads placed upon it. As these loads are decreased (e.g., when the patient reclines), the amoφhous polymer core 22 reforms, as a whole, back to a more circular cross- sectional shape. Effectively then, the constraining jacket 24 directs the amoφhous polymer core 22 to reform, as a whole, vertically within the nucleus cavity 66. This controlled reformation pushes apart or further separates the adjacent vertebrae 62 (FIGS. 5 and 8), as would a normal nucleus.
The prosthetic spinal disc nucleus 20 also restores the natural fluid pumping action of the disc space 60. The hydrated prosthetic spinal disc nucleus 20 occupies a certain percentage, but not all of, the nucleus cavity 66. As loads on the disc space 60 increase, the prosthetic spinal disc nucleus 20 cushions the vertebral end plates (not shown) and slowly deforms. As a result, the volume within the nucleus cavity 60 decreases. Notably, because the prosthetic spinal disc nucleus 20 does not occupy the entire nucleus cavity 66, there is room for the prosthetic spinal disc nucleus 20 to deform, and the reduction in volume of the nucleus cavity 66 is allowed to take place as would otherwise occur with a normal nucleus. In this regard, the amoφhous polymer core 22 will flatten or deform as a whole, but not decrease in volume in response to the load so that the prosthetic spinal disc nucleus
18 20 now occupies a larger percentage of the nucleus cavity 66. As a result of the reduction in space, fluids otherwise found in the nucleus cavity 66 are forced out of the disc space 60, thus flushing out the accumulated acids or autotoxins contained therein. Due to the preferred granule nature of the amoφhous polymer core 22, more unbound or loosely bound water will flow into and out of the amoφhous polymer core 22 then if a singular block material were used.
Conversely, when the load is removed or decreased, the prosthetic spinal disc nucleus 20 reforms to a more circular cross-sectional shape. This entails an increase in the vertical direction (relative to the spine in an upright position), causing the vertebral end plates (not shown) to separate, creating an increased volume in the nucleus cavity 66. It will be remembered that the amoφhous polymer core 22 does not increase in volume, but simply reforms. As a result, bodily fluid, containing beneficial nutrients, fills the now- increased volume of the nucleus cavity 66, revitalizing the overall disc space 60. The prosthetic spinal disc nucleus 20 acts in concert with the natural disc space 60 to restore the natural pumping action of the disc space 60.
Notably, the prosthetic spinal disc nucleus 20 of the present invention independently absorbs the force/pressure placed upon the disc space 60. Thus, the anulus 64 is not required to support the force/pressure generated by swelling of the amoφhous polymer core 22 during hydration. The anulus 64 does not provide any circumferential support to the prosthetic spinal disc nucleus 20.
E. Alternative Prosthetic Spinal Disc Nucleus Utilizing Hydrogel Material
An alternative embodiment of a prosthetic spinal disc nucleus 120 is shown in FIGS. 9 and 10. The prosthetic spinal disc nucleus 120 is highly similar to that previously described, in that it is comprised of an amoφhous polymer core 122 and a constraining jacket 124. The constraining jacket 124 is identical to the constraining jacket 24 (FIG. 1) previously described, and includes an anterior end 126, a posterior end 128, an anterior closure 130 and a posterior closure 132. The amoφhous polymer core 122, however, is defined by a plurality of hydrogel microchips. The plurality of hydrogel microchips 122 are preferably made from the same hydrogel material set forth above. Unlike the previously described amoφhous
19 polymer core 22 (FIG. 1), however, the plurality of hydrogel microchips 122 are manufactured to have a certain shape.
FIGS. 11-15 illustrate the manufacturing of the prosthetic spinal disc nucleus 120. First, a block 140 of hydrogel material is provided. The material making up the block 140 of hydrogel is preferably polyacrylonitrile, although other materials may also be useful. The block 140 of hydrogel material can be cast in any shape. In a preferred embodiment, the block 140 of hydrogel material is a cast or extruded rod of polymer approximately one millimeter in diameter. Alternatively, other dimensions may also be useful. The block 140 of hydrogel material is fed into a holding channel (not shown) associated with a milling machine 142, as shown in FIG. 11. In a preferred embodiment, the milling machine 142 is a rotating hobbing mill 142 having a number of cutting edges 144. As the block 140 of hydrogel material is fed toward the milling machine 142, the cutting edges 144 cut the block 140 of hydrogel material, creating the plurality of hydrogel microchips 122. Because the block 140 of hydrogel is preferably amoφhous and semi-rigid, the cutting edges 144 are able to easily cut the hydrogel material, resulting in a relatively uniform shape.
In a preferred embodiment, each of the plurality of hydrogel microchips 122 is approximately wedge-shaped. For example, as shown in FIG. 12A, each of the plurality of hydrogel microchips 122 is a crescent-shaped wedge, defined by a convex surface 146 and a concave surface 148. Alternatively, as shown in FIG. 12B, each of a plurality of hydrogel microchips 122 may have a more oval contour, including a slight concavity on one surface 150. Even further, as shown in FIG. 12C, each of a plurality of hydrogel microchips 122 can alternatively be an elongated body, having opposing relatively flat surfaces.
As shown by the above-described figures, the plurality of hydrogel microchips 122 can assume any of a number of wedge-shaped configurations. Preferably, however, the particular shape generated facilitates tight stacking between each of the plurality of hydrogel microchips 122. In this regard, the final shape of each of the plurality of hydrogel microchips 122 is not spherical so that at least a portion of the outer surface is not convex. With this design, the plurality of
20 hydrogel microchips 122 can be closely compacted within the constraining jacket 124 (FIG. 11), as described in greater detail below.
Following the cutting process, the plurality of hydrogel microchips 122 are placed into a tumbler apparatus 152, as shown in FIG. 13. In a preferred embodiment, the tumbler apparatus 152 includes a drum 154 driven by an obliquely-mounted motor shaft 156. Alternatively, other similar devices may also be used.
The plurality of hydrogel microchips 122 are first dry tumbled in the tumbler apparatus 152 so as to slightly dull their outer surface. Thus, the tumbling process abrades and polishes each of the plurality of hydrogel microchips 122, smoothing any shaφ points or edges.
Any excess material removed during the dry tumbling process is separated from the drum 154, such as by a simple blowing process. Alternatively, a microfilter can be provided to filter the fine particulates from the plurality of hydrogel microchips 122 otherwise maintained in the drum 154. Following the dry tumbling process, the plurality of hydrogel microchips 122 may be slightly flattened between rotating rollers (not shown) to increase a packing density of the plurality of hydrogel microchips 122.
In the final stages of tumbling, the plurality of hydrogel microchips 122 are tumble-coated with another, softer, low friction formulation of hydrogel. The hydrogel coating may be any suitable, stable, appropriately hygroscopic material.
For example, the coating may be a separate polymer having characteristics different from the material of the plurality of hydrogel microchips 122, such as a different shear behavior. Regardless of exact form, the polymer coating facilitates deformation or sliding between individual particles of the plurality of hydrogel microchips 122. As a result, a total mass formed by the plurality of hydrogel microchips 122 exhibits a deformable attribute, and is able to conform to minor variations within a nucleus cavity. In a preferred embodiment, a lower friction polyvinyl alcohol or polyacrylonitrile is used as the coating, although other similar materials may also be useful. The coating is formed as a fine, aquatic slurry that is slowly added to the drum 154 while continuously tumbling the plurality of hydrogel microchips 122. The coating material naturally adheres to the plurality of hydrogel
21 microchips 122, forming a thin film. Following an appropriate dwell period, each of the plurality of hydrogel microchips 122 individually become thinly coated with the coating material, creating a bonded, smooth surface.
Once properly coated, the plurality of hydrogel microchips 122 are subjected to warm, filtered air and slowly dehydrated. In a preferred embodiment, forced air at a temperature of less than 100C is blown on the plurality of hydrogel microchips 122 while the drum 154 continues to rotate. The polishing, tumble coating and dehydration process results in coarse, free-flowing microchips, each having an approximately wedge shape. It should be recognized that adjustments can be made in several parameters in order to achieve the desired static and dynamic behavior of the plurality of hydrogel microchips 122. For example, the viscosity and swelling behavior of the initial block 140 (FIG. 13) of hydrogel; the size and shape of each of the plurality of hydrogel microchips 122; the coefficient of friction and swelling behavior of the coating gel; and the thickness of the coating layer may be altered to achieve desired performance characteristics.
Following the tumbling process, the plurality of hydrogel microchips 122 are placed within the constraining jacket 124, as shown in FIG. 16. As previously described, the constraining jacket 124 is preferably a high molecular weight, polyethylene-woven jacket. Prior to placement of the plurality of hydrogel microchips 122, the consfraining jacket 124 is closed at the posterior end 128 by the posterior closure 132. Any excess material at the posterior end 128 is removed by a thermal cut, fusing posterior closure 132.
The plurality of hydrogel microchips 122 (FIG. 13) are poured into the constraining jacket 124 at the open, anterior end 126. The anterior end 126 is then closed and any excess material is removed from the anterior end 126 by a thermal cut, fusing the anterior closure 130.
F. Alternative Prosthetic Spinal Disc Nucleus Utilizing Non- Hydrophilic Polymer As described above, the preferred prosthetic spinal disc nucleus 20 (FIG. 1) employs a hydrogel material for the amoφhous polymer core 22 (FIG. 1). It should be recognized, however, that non-hydrophilic, biocompatible polymers may also be
22 useful. In particular, a non-hydrophilic polymer that is flowable (or can be maintained flowable) in a first state and cured or non-flowable in a second state can be used. It should be understood that the term "non-hydrophilic" as used in this specification, encompasses not only hydrophilic materials, but also materials with a slight affinity to water. Thus, any material that cannot imbibe and maintain a significant amount of water relative to an overall volume of the material is considered "non-hydrophilic". The "flowable" first state can be achieved in a number of different manners, such as by retaining the polymer in a solvent that later is released, use of a catalyst, heating the polymer to a molten state, etc. For example, silicone rubber (RTV) with acetic acid is flowable; once exposed, however, the acid is released and the silicone rubber cures.
While the non-hydrophilic polymer does not imbibe a significant amount of fluid, the resulting prosthetic spinal disc nucleus is basically identical to the preferred prosthetic spinal disc nucleus 20 shown in FIGS. 1 and 2. In other words, the substantially inelastic constraining jacket 24 is implanted into the disc space, and the amoφhous polymer core 22 is percutaneously inserted into the constraining jacket 24, such as by a syringe. With the alternative embodiment, the non- hydrophilic polymer used for the amoφhous polymer core 22 is inserted into the constraining jacket 24 in the first, flowable state, filling an initial volume of the • constraining jacket 24 (which is less than the generally fixed maximum volume).
As additional material is forced into the constraining jacket 24, a filling pressure is developed, causing the constraining jacket 24 to transition from the initial volume to the generally fixed maximum volume, increasing substantially in height ("x" in FIG. 2). In other words, the constraining jacket transitions from a flattened, oval shape to a more circular cross-section. This structural characteristic of the constraining jacket 24 is identical to the previous embodiments and results in necessary spacing between adjacent vertebrae. Once filling of the constraining jacket 24 is complete, the amoφhous polymer core 22 cures, preferably remaining somewhat compliant. In the cured state, the prosthetic spinal disc nucleus 20 functions identically to the previous embodiments, acting in concert with the disc space to pump fluids into and out of the nucleus cavity.
23 The prosthetic spinal disc nucleus of the present invention: a) restores the height of the damaged disc space; b) restores and tightens the natural anulus to stop further degeneration and permit its healing; c) restores the normal load-unload cycling and thus flushes out toxic by-products, bringing in fresh nutrients to the disc space; d) allows a near-normal range of motion; e) relieves the movement-induced discogenic pain of the vertebral segment; and f) allows the use of a minimal, posterior surgical procedure that provides both cost and medical benefits. In short, the prosthetic spinal disc nucleus of the present invention has the ability to elevate the disc space from the inside, as does the normal, highly hygroscopic nucleus. It will tighten the ligamentous anulus and therefore promote the health and repairability of anular fibers. Beyond these functions, the prosthetic spinal disc nucleus of the present invention has the unique ability to conform to contours of the available internal nucleus cavity. Further, the prosthetic spinal disc nucleus will exhibit shear behavior under load, imitating the normal, constrained rheology of the natural disc nucleus. Finally, hospital inventory costs are greatly reduced in that the final size of the prosthetic spinal disc nucleus need not be determined until actual surgery. The surgeon then simply chooses an appropriately sized constraining jacket and subsequently inserts a sufficient amount of the amoφhous polymer core.
Although the present invention has been described with reference to preferred embodiments, workers skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the invention. For example, other methods of sealing the ends of the constraining jacket exist, such as heat, ultrasound, crimp ring seals or spin entanglement. Additionally, more than a single layer of material may be used to maintain the integrity of the amoφhous polymer core. In other words, a plurality of jackets can surround the amoφhous polymer core with one layer providing efficient filtering of the amoφhous polymer core and assure full containment, and a second layer providing strength.
24

Claims

What is claimed is:
1. A prosthetic spinal disc nucleus for implantation into a nucleus cavity of a spinal disc, the nucleus cavity defined by an opposing pair of vertebral bodies, forming opposing end plates, and an anulus, the prosthetic spinal disc nucleus comprising: a substantially inelastic constraining jacket having a generally fixed maximum volume determined by a generally fixed circumference and length, the maximum volume being less than a volume of the nucleus cavity, wherein the constraining jacket defines a height corresponding to a plane substantially peφendicular to the opposing end plates; and an amoφhous polymer core inserted into the constraining jacket, the polymer core configured to be flowable in at least a first state such that upon insertion, the polymer core fills an initial volume of the constraining jacket and creates an internal pressure within the constraining jacket, the constraining jacket being configured to transition from the initial volume toward the maximum volume, increasing substantially in height in response to the internal pressure.
2. The prosthetic spinal disc nucleus of claim 1, wherein the amoφhous polymer core is configured to conform to a contour of the disc space.
3. The prosthetic spinal disc nucleus of claim 1, wherein the amoφhous polymer core is a non-hydrophilic polymer, and wherein the internal pressure is a filling pressure of the amoφhous polymer core upon insertion into the constraining jacket.
4. The prosthetic spinal disc nucleus of claim 1 , wherein the amoφhous polymer core is a hydrogel configured to expand from an unhydrated state to a hydrated state.
25
5. The prosthetic spinal disc nucleus of claim 4, wherein the maximum volume of the constraining jacket is greater than a volume of the amoφhous polymer core in the unhydrated state, but less than a volume of the amoφhous polymer core in the hydrated state, and wherein the internal pressure is a swelling pressure of the amoφhous polymer core transitioning from the unhydrated state to the hydrated state.
6. The prosthetic spinal disc nucleus of claim 4, wherein the hydrogel is a hydrogel powder.
7. The prosthetic spinal disc nucleus of claim 6, wherein the hydrogel powder consists of a plurality of irregularly shaped granules.
8. The prosthetic spinal disc nucleus of claim 7, wherein each of the plurality of irregularly shaped granules is flattened, having a height less than a width or a length.
9. The prosthetic spinal disc nucleus of claim 7, wherein the plurality of irregularly shaped granules is coated with a low friction material.
10. The prosthetic spinal disc nucleus of claim 6 wherein the hydrogel powder includes a plurality of non-spherical granules.
11. The prosthetic spinal disc nucleus of claim 6, wherein the hydrogel powder is suspended in a viscous liquid.
12. The prosthetic spinal disc nucleus of claim 4, wherein the hydrogel is a fluid hydrogel.
13. The prosthetic spinal disc nucleus of claim 12, wherein the fluid hydrogel is configured to congeal upon contact with water.
26
14. The prosthetic spinal disc nucleus of claim 13, wherein the fluid hydrogel is non-thixotropic.
15. The prosthetic spinal disc nucleus of claim 1, wherein the amoφhous polymer core comprises a plurality of hydrogel microchips.
16. The prosthetic spinal disc nucleus of claim 15, wherein at least a portion of an outer surface of each of the plurality of hydrogel microchips is flattened.
17. A method of manufacturing a prosthetic spinal disc nucleus implanted into a nucleus cavity of a spinal disc, the method comprising: providing a substantially inelastic constraining jacket having a generally fixed maximum volume determined by a generally fixed circumference and length, the maximum volume being less than a volume of the nucleus cavity, and wherein the constraining jacket defines a height corresponding to a transverse plane of the nucleus cavity; providing an amoφhous polymer core that is flowable in at least a first state; inserting the amoφhous polymer core in the first state into the constraining jacket such that the amoφhous polymer core fills an initial volume of the constraining jacket; and generating an internal pressure within the constraining jacket, wherein the constraining jacket transitions from the initial volume toward the maximum volume, increasing substantially in height in response to the internal pressure.
18. The method of claim 17, wherein providing an amoφhous polymer core includes forming a hydrogel configured to expand from an unhydrated state to a hydrated state.
27
19. The method of claim 18, wherein the amoφhous polymer core is inserted into the constraining jacket in the unhydrated state, and wherein generating an internal pressure includes hydrating the amoφhous polymer core to the hydrated state.
20. The method of claim 17, wherein the amoφhous polymer core is a non- hydrophilic polymer and wherein generating an internal pressure includes injecting a volume of the non-hydrophilic polymer into the constraining jacket greater than the initial volume of the constraining jacket to develop a filling pressure.
21. The method of claim 17, wherein providing an amoφhous polymer core includes providing a hydrogel powder.
22. The method of claim 21, wherein providing an amoφhous polymer core further includes: coating individual grains of the hydrogel powder with a low-viscosity material.
23. The method of claim 17, wherein providing an amoφhous polymer core includes suspending a hydrogel powder in a viscous liquid.
24. The method of claim 17, wherein providing an amoφhous polymer core includes providing a fluid hydrogel.
25. The method of claim 24, wherein providing a fluid hydrogel includes dissolving a hydrogel powder in a solvent such that the fluid hydrogel will congeal upon hydration.
26. The method of claim 17, wherein providing an amoφhous polymer core includes forming a plurality of hydrogel microchips.
28
PCT/US1999/005757 1998-03-16 1999-03-16 Percutaneous prosthetic spinal disc nucleus and method of manufacture WO1999047082A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE69935425T DE69935425T2 (en) 1998-03-16 1999-03-16 Percutaneous disc prosthesis and manufacturing process
CA002323922A CA2323922C (en) 1998-03-16 1999-03-16 Percutaneous prosthetic spinal disc nucleus and method of manufacture
AU30076/99A AU742901B2 (en) 1998-03-16 1999-03-16 Percutaneous prosthetic spinal disc nucleus and method of manufacture
BR9908824-0A BR9908824A (en) 1998-03-16 1999-03-16 Percutaneous prosthetic spinal disc core and manufacturing process
EP99911436A EP1063948B1 (en) 1998-03-16 1999-03-16 Percutaneous prosthetic spinal disc nucleus and method of manufacture
JP2000536325A JP2002506678A (en) 1998-03-16 1999-03-16 Disc nucleus pulposus prosthesis for percutaneous transplantation and method of manufacturing the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/039,582 US6022376A (en) 1997-06-06 1998-03-16 Percutaneous prosthetic spinal disc nucleus and method of manufacture
US09/039,582 1998-03-16

Publications (1)

Publication Number Publication Date
WO1999047082A1 true WO1999047082A1 (en) 1999-09-23

Family

ID=21906240

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/005757 WO1999047082A1 (en) 1998-03-16 1999-03-16 Percutaneous prosthetic spinal disc nucleus and method of manufacture

Country Status (12)

Country Link
US (1) US6022376A (en)
EP (1) EP1063948B1 (en)
JP (3) JP2002506678A (en)
KR (1) KR100647762B1 (en)
AT (1) ATE355802T1 (en)
AU (1) AU742901B2 (en)
BR (1) BR9908824A (en)
CA (1) CA2323922C (en)
DE (1) DE69935425T2 (en)
ES (1) ES2283108T3 (en)
WO (1) WO1999047082A1 (en)
ZA (1) ZA200005580B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000059412A1 (en) * 1999-04-05 2000-10-12 Raymedica, Inc. Prosthetic spinal disc nucleus having a shape change characteristic
US6652585B2 (en) 2001-02-28 2003-11-25 Sdgi Holdings, Inc. Flexible spine stabilization system
US6827743B2 (en) 2001-02-28 2004-12-07 Sdgi Holdings, Inc. Woven orthopedic implants
WO2005002474A1 (en) * 2003-07-02 2005-01-13 Jong Wuk Jang Disk therapy implant, and operation method of implant
US7156877B2 (en) 2001-06-29 2007-01-02 The Regents Of The University Of California Biodegradable/bioactive nucleus pulposus implant and method for treating degenerated intervertebral discs
US7229441B2 (en) 2001-02-28 2007-06-12 Warsaw Orthopedic, Inc. Flexible systems for spinal stabilization and fixation
US7682392B2 (en) 2002-10-30 2010-03-23 Depuy Spine, Inc. Regenerative implants for stabilizing the spine and devices for attachment of said implants
WO2011136824A1 (en) * 2010-04-27 2011-11-03 Adnan Iqbal Qureshi Intraspinal device deployed through percutaneous approach into subarachnoid or intradural space of vertebral canal to protect spinal cord from external compression

Families Citing this family (429)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020939A2 (en) * 1996-11-15 1998-05-22 Advanced Bio Surfaces, Inc. Biomaterial system for in situ tissue repair
US5674296A (en) 1994-11-14 1997-10-07 Spinal Dynamics Corporation Human spinal disc prosthesis
US20020143331A1 (en) * 1998-10-20 2002-10-03 Zucherman James F. Inter-spinous process implant and method with deformable spacer
US20080027552A1 (en) * 1997-01-02 2008-01-31 Zucherman James F Spine distraction implant and method
US8128661B2 (en) * 1997-01-02 2012-03-06 Kyphon Sarl Interspinous process distraction system and method with positionable wing and method
US6712819B2 (en) 1998-10-20 2004-03-30 St. Francis Medical Technologies, Inc. Mating insertion instruments for spinal implants and methods of use
US7201751B2 (en) * 1997-01-02 2007-04-10 St. Francis Medical Technologies, Inc. Supplemental spine fixation device
US7101375B2 (en) * 1997-01-02 2006-09-05 St. Francis Medical Technologies, Inc. Spine distraction implant
US5836948A (en) 1997-01-02 1998-11-17 Saint Francis Medical Technologies, Llc Spine distraction implant and method
US6902566B2 (en) * 1997-01-02 2005-06-07 St. Francis Medical Technologies, Inc. Spinal implants, insertion instruments, and methods of use
US20080086212A1 (en) * 1997-01-02 2008-04-10 St. Francis Medical Technologies, Inc. Spine distraction implant
US20080071378A1 (en) * 1997-01-02 2008-03-20 Zucherman James F Spine distraction implant and method
US7959652B2 (en) 2005-04-18 2011-06-14 Kyphon Sarl Interspinous process implant having deployable wings and method of implantation
US6695842B2 (en) * 1997-10-27 2004-02-24 St. Francis Medical Technologies, Inc. Interspinous process distraction system and method with positionable wing and method
US6068630A (en) * 1997-01-02 2000-05-30 St. Francis Medical Technologies, Inc. Spine distraction implant
US20080039859A1 (en) * 1997-01-02 2008-02-14 Zucherman James F Spine distraction implant and method
US7306628B2 (en) * 2002-10-29 2007-12-11 St. Francis Medical Technologies Interspinous process apparatus and method with a selectably expandable spacer
US6796983B1 (en) 1997-01-02 2004-09-28 St. Francis Medical Technologies, Inc. Spine distraction implant and method
US6514256B2 (en) 1997-01-02 2003-02-04 St. Francis Medical Technologies, Inc. Spine distraction implant and method
GB9714580D0 (en) * 1997-07-10 1997-09-17 Wardlaw Douglas Prosthetic intervertebral disc nucleus
CA2307888C (en) 1997-10-27 2007-09-18 Saint Francis Medical Technologies, Inc. Spine distraction implant
US5932552A (en) 1997-11-26 1999-08-03 Keraplast Technologies Ltd. Keratin-based hydrogel for biomedical applications and method of production
EP1102568A1 (en) 1998-08-06 2001-05-30 SDGI Holdings, Inc. Composited intervertebral bone spacers
US6187000B1 (en) 1998-08-20 2001-02-13 Endius Incorporated Cannula for receiving surgical instruments
CA2342633C (en) * 1998-09-04 2007-11-13 Spinal Dynamics Corporation Peanut spectacle multi discoid thoraco-lumbar disc prosthesis
SE515572C2 (en) * 1998-09-09 2001-09-03 Lanka Ltd Implants, ways of making it and using it
US7029473B2 (en) * 1998-10-20 2006-04-18 St. Francis Medical Technologies, Inc. Deflectable spacer for use as an interspinous process implant and method
US7189234B2 (en) 1998-10-20 2007-03-13 St. Francis Medical Technologies, Inc. Interspinous process implant sizer and distractor with a split head and size indicator and method
US6652534B2 (en) 1998-10-20 2003-11-25 St. Francis Medical Technologies, Inc. Apparatus and method for determining implant size
US6652527B2 (en) 1998-10-20 2003-11-25 St. Francis Medical Technologies, Inc. Supplemental spine fixation device and method
AU2999900A (en) 1999-02-18 2000-09-04 Ken Y. Hsu Hair used as a biologic disk, replacement, and/or structure and method
US6436143B1 (en) * 1999-02-22 2002-08-20 Anthony C. Ross Method and apparatus for treating intervertebral disks
CA2594492A1 (en) 1999-03-07 2000-09-14 Active Implants Corporation Method and apparatus for computerized surgery
US20060247665A1 (en) * 1999-05-28 2006-11-02 Ferree Bret A Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft
US7273497B2 (en) * 1999-05-28 2007-09-25 Anova Corp. Methods for treating a defect in the annulus fibrosis
US20070038231A1 (en) 1999-05-28 2007-02-15 Ferree Bret A Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft
US6419704B1 (en) * 1999-10-08 2002-07-16 Bret Ferree Artificial intervertebral disc replacement methods and apparatus
FR2797179B1 (en) * 1999-08-03 2002-03-08 Michel Gau INTERVERTEBRAL NUCLEAR PROSTHESIS AND SURGICAL IMPLANTATION METHOD
US7435260B2 (en) * 1999-08-13 2008-10-14 Ferree Bret A Use of morphogenetic proteins to treat human disc disease
US7201776B2 (en) * 1999-10-08 2007-04-10 Ferree Bret A Artificial intervertebral disc replacements with endplates
US6755863B2 (en) * 1999-10-08 2004-06-29 Bret A. Ferree Rotator cuff repair using engineered tissues
US6783546B2 (en) 1999-09-13 2004-08-31 Keraplast Technologies, Ltd. Implantable prosthetic or tissue expanding device
US6371984B1 (en) * 1999-09-13 2002-04-16 Keraplast Technologies, Ltd. Implantable prosthetic or tissue expanding device
US6645247B2 (en) * 1999-10-08 2003-11-11 Bret A. Ferree Supplementing engineered annulus tissues with autograft of allograft tendons
US6875235B2 (en) * 1999-10-08 2005-04-05 Bret A. Ferree Prosthetic joints with contained compressible resilient members
US20040186573A1 (en) * 1999-10-08 2004-09-23 Ferree Bret A. Annulus fibrosis augmentation methods and apparatus
US20030004574A1 (en) * 1999-10-08 2003-01-02 Ferree Bret A. Disc and annulus augmentation using biologic tissue
US20030026788A1 (en) * 1999-10-08 2003-02-06 Ferree Bret A. Use of extracellular matrix tissue to preserve cultured cell phenotype
US7060100B2 (en) * 1999-10-08 2006-06-13 Ferree Bret A Artificial disc and joint replacements with modular cushioning components
US20040172019A1 (en) * 1999-10-08 2004-09-02 Ferree Bret A. Reinforcers for artificial disc replacement methods and apparatus
US7201774B2 (en) * 1999-10-08 2007-04-10 Ferree Bret A Artificial intervertebral disc replacements incorporating reinforced wall sections
US6648920B2 (en) * 1999-10-08 2003-11-18 Bret A. Ferree Natural and synthetic supplements to engineered annulus and disc tissues
US20030191474A1 (en) * 2000-02-16 2003-10-09 Cragg Andrew H. Apparatus for performing a discectomy through a trans-sacral axial bore within the vertebrae of the spine
US7727263B2 (en) * 2000-02-16 2010-06-01 Trans1, Inc. Articulating spinal implant
US7500977B2 (en) * 2003-10-23 2009-03-10 Trans1 Inc. Method and apparatus for manipulating material in the spine
US6899716B2 (en) * 2000-02-16 2005-05-31 Trans1, Inc. Method and apparatus for spinal augmentation
US6740093B2 (en) * 2000-02-28 2004-05-25 Stephen Hochschuler Method and apparatus for treating a vertebral body
US6332894B1 (en) * 2000-03-07 2001-12-25 Zimmer, Inc. Polymer filled spinal fusion cage
US6689125B1 (en) 2000-04-04 2004-02-10 Spinalabs, Llc Devices and methods for the treatment of spinal disorders
US6579291B1 (en) 2000-10-10 2003-06-17 Spinalabs, Llc Devices and methods for the treatment of spinal disorders
US6402750B1 (en) 2000-04-04 2002-06-11 Spinlabs, Llc Devices and methods for the treatment of spinal disorders
US6805695B2 (en) * 2000-04-04 2004-10-19 Spinalabs, Llc Devices and methods for annular repair of intervertebral discs
US20030229348A1 (en) * 2000-05-25 2003-12-11 Sevrain Lionel C. Auxiliary vertebrae connecting device
AU2001261969A1 (en) * 2000-05-25 2001-12-03 Neurortho Implants Design, Llc Inter-vertebral disc prosthesis for rachis for an anterior surgery thereof
US6533817B1 (en) 2000-06-05 2003-03-18 Raymedica, Inc. Packaged, partially hydrated prosthetic disc nucleus
USD494274S1 (en) 2000-06-12 2004-08-10 Ortho Development Corporation Implant
US6579318B2 (en) * 2000-06-12 2003-06-17 Ortho Development Corporation Intervertebral spacer
US7025771B2 (en) * 2000-06-30 2006-04-11 Spineology, Inc. Tool to direct bone replacement material
DE60141653D1 (en) * 2000-07-21 2010-05-06 Spineology Group Llc A STRONG, POROUS NET BAG DEVICE AND ITS USE IN BONE SURGERY
US20080086133A1 (en) * 2003-05-16 2008-04-10 Spineology Expandable porous mesh bag device and methods of use for reduction, filling, fixation and supporting of bone
US7056321B2 (en) * 2000-08-01 2006-06-06 Endius, Incorporated Method of securing vertebrae
US7985247B2 (en) 2000-08-01 2011-07-26 Zimmer Spine, Inc. Methods and apparatuses for treating the spine through an access device
US7601174B2 (en) * 2000-08-08 2009-10-13 Warsaw Orthopedic, Inc. Wear-resistant endoprosthetic devices
US6949105B2 (en) * 2000-08-08 2005-09-27 Sdgi Holdings, Inc. Method and apparatus for stereotactic implantation
CA2429246C (en) * 2000-08-08 2011-06-07 Vincent Bryan Implantable joint prosthesis
US20020035400A1 (en) 2000-08-08 2002-03-21 Vincent Bryan Implantable joint prosthesis
US7125380B2 (en) * 2000-08-08 2006-10-24 Warsaw Orthopedic, Inc. Clamping apparatus and methods
US7503936B2 (en) * 2000-08-30 2009-03-17 Warsaw Orthopedic, Inc. Methods for forming and retaining intervertebral disc implants
US7204851B2 (en) * 2000-08-30 2007-04-17 Sdgi Holdings, Inc. Method and apparatus for delivering an intervertebral disc implant
US20050154463A1 (en) * 2000-08-30 2005-07-14 Trieu Hal H. Spinal nucleus replacement implants and methods
US20020026244A1 (en) * 2000-08-30 2002-02-28 Trieu Hai H. Intervertebral disc nucleus implants and methods
US6620196B1 (en) 2000-08-30 2003-09-16 Sdgi Holdings, Inc. Intervertebral disc nucleus implants and methods
US6582467B1 (en) * 2000-10-31 2003-06-24 Vertelink Corporation Expandable fusion cage
US6692528B2 (en) * 2000-11-09 2004-02-17 The Polymer Technology Group Incorporated Devices that change size/shape via osmotic pressure
US6896692B2 (en) 2000-12-14 2005-05-24 Ensure Medical, Inc. Plug with collet and apparatus and method for delivering such plugs
US6890343B2 (en) * 2000-12-14 2005-05-10 Ensure Medical, Inc. Plug with detachable guidewire element and methods for use
US20020169507A1 (en) 2000-12-14 2002-11-14 David Malone Interbody spine fusion cage
US6623509B2 (en) 2000-12-14 2003-09-23 Core Medical, Inc. Apparatus and methods for sealing vascular punctures
US6846319B2 (en) * 2000-12-14 2005-01-25 Core Medical, Inc. Devices for sealing openings through tissue and apparatus and methods for delivering them
US8083768B2 (en) 2000-12-14 2011-12-27 Ensure Medical, Inc. Vascular plug having composite construction
US6562045B2 (en) 2001-02-13 2003-05-13 Sdgi Holdings, Inc. Machining apparatus
US20020147496A1 (en) 2001-04-06 2002-10-10 Integrated Vascular Systems, Inc. Apparatus for treating spinal discs
US20040083002A1 (en) * 2001-04-06 2004-04-29 Belef William Martin Methods for treating spinal discs
US6582433B2 (en) 2001-04-09 2003-06-24 St. Francis Medical Technologies, Inc. Spine fixation device and method
US6632235B2 (en) * 2001-04-19 2003-10-14 Synthes (U.S.A.) Inflatable device and method for reducing fractures in bone and in treating the spine
EP1399100A1 (en) * 2001-06-27 2004-03-24 Mathys Medizinaltechnik AG Intervertebral disk prosthesis
US20090234457A1 (en) * 2001-06-29 2009-09-17 The Regents Of The University Of California Systems, devices and methods for treatment of intervertebral disorders
US6926728B2 (en) * 2001-07-18 2005-08-09 St. Francis Medical Technologies, Inc. Curved dilator and method
FR2828398B1 (en) * 2001-08-08 2003-09-19 Jean Taylor VERTEBRA STABILIZATION ASSEMBLY
US6736815B2 (en) * 2001-09-06 2004-05-18 Core Medical, Inc. Apparatus and methods for treating spinal discs
US7025787B2 (en) * 2001-11-26 2006-04-11 Sdgi Holdings, Inc. Implantable joint prosthesis and associated instrumentation
MXPA04005707A (en) * 2001-12-10 2005-06-20 Colbar Lifescience Ltd D Methods, devices, and preparations for intervertebral disc treatment.
US6736850B2 (en) * 2001-12-28 2004-05-18 Spinal Concepts, Inc. Vertebral pseudo arthrosis device and method
US20060129242A1 (en) * 2001-12-28 2006-06-15 Brian Bergeron Pseudo arthrosis device
US7011684B2 (en) * 2002-01-17 2006-03-14 Concept Matrix, Llc Intervertebral disk prosthesis
US7235102B2 (en) * 2002-05-10 2007-06-26 Ferree Bret A Prosthetic components with contained compressible resilient members
US7066958B2 (en) * 2002-05-10 2006-06-27 Ferree Bret A Prosthetic components with partially contained compressible resilient members
US20040024461A1 (en) * 2002-05-10 2004-02-05 Ferree Bret A. Spring and spherical joint artificial disc replacements
US7291171B2 (en) * 2002-05-10 2007-11-06 Ferree Bret A Artificial disc replacement (ADR) using elastic tether member
US7001433B2 (en) 2002-05-23 2006-02-21 Pioneer Laboratories, Inc. Artificial intervertebral disc device
US8388684B2 (en) * 2002-05-23 2013-03-05 Pioneer Signal Technology, Inc. Artificial disc device
US20040049283A1 (en) * 2002-06-04 2004-03-11 Tushar Patel Medical implant and method of reducing back pain
FR2844179B1 (en) * 2002-09-10 2004-12-03 Jean Taylor POSTERIOR VERTEBRAL SUPPORT KIT
US20040054414A1 (en) * 2002-09-18 2004-03-18 Trieu Hai H. Collagen-based materials and methods for augmenting intervertebral discs
US7744651B2 (en) * 2002-09-18 2010-06-29 Warsaw Orthopedic, Inc Compositions and methods for treating intervertebral discs with collagen-based materials
EP2002805A3 (en) * 2002-09-19 2009-01-07 Malan De Villiers Intervertebral prosthesis
US7497859B2 (en) * 2002-10-29 2009-03-03 Kyphon Sarl Tools for implanting an artificial vertebral disk
US7909853B2 (en) * 2004-09-23 2011-03-22 Kyphon Sarl Interspinous process implant including a binder and method of implantation
US7273496B2 (en) * 2002-10-29 2007-09-25 St. Francis Medical Technologies, Inc. Artificial vertebral disk replacement implant with crossbar spacer and method
US7833246B2 (en) * 2002-10-29 2010-11-16 Kyphon SÀRL Interspinous process and sacrum implant and method
US20050075634A1 (en) * 2002-10-29 2005-04-07 Zucherman James F. Interspinous process implant with radiolucent spacer and lead-in tissue expander
US8070778B2 (en) * 2003-05-22 2011-12-06 Kyphon Sarl Interspinous process implant with slide-in distraction piece and method of implantation
US20060271194A1 (en) * 2005-03-22 2006-11-30 St. Francis Medical Technologies, Inc. Interspinous process implant having deployable wing as an adjunct to spinal fusion and method of implantation
US20060264939A1 (en) * 2003-05-22 2006-11-23 St. Francis Medical Technologies, Inc. Interspinous process implant with slide-in distraction piece and method of implantation
US6966929B2 (en) * 2002-10-29 2005-11-22 St. Francis Medical Technologies, Inc. Artificial vertebral disk replacement implant with a spacer
US20060064165A1 (en) * 2004-09-23 2006-03-23 St. Francis Medical Technologies, Inc. Interspinous process implant including a binder and method of implantation
US20080021468A1 (en) * 2002-10-29 2008-01-24 Zucherman James F Interspinous process implants and methods of use
US7549999B2 (en) * 2003-05-22 2009-06-23 Kyphon Sarl Interspinous process distraction implant and method of implantation
US7749252B2 (en) 2005-03-21 2010-07-06 Kyphon Sarl Interspinous process implant having deployable wing and method of implantation
US8147548B2 (en) * 2005-03-21 2012-04-03 Kyphon Sarl Interspinous process implant having a thread-shaped wing and method of implantation
US7083649B2 (en) * 2002-10-29 2006-08-01 St. Francis Medical Technologies, Inc. Artificial vertebral disk replacement implant with translating pivot point
US8048117B2 (en) * 2003-05-22 2011-11-01 Kyphon Sarl Interspinous process implant and method of implantation
US20040133278A1 (en) * 2002-10-31 2004-07-08 Marino James F. Spinal disc implant
NZ539779A (en) * 2002-11-05 2009-01-31 Spineology Inc A semi-biological intervertebral disc replacement system created by inserting tissue promoting material into a cavity in the disc
CN100394989C (en) * 2002-11-15 2008-06-18 华沙整形外科股份有限公司 Collagen-based materials and methods for augmenting intervertebral discs
US20040186471A1 (en) * 2002-12-07 2004-09-23 Sdgi Holdings, Inc. Method and apparatus for intervertebral disc expansion
WO2004064673A2 (en) * 2003-01-17 2004-08-05 Psinergi Corporation Artificial nucleus pulposus and method of injecting same
EP2329778A3 (en) * 2003-01-31 2012-06-20 Spinalmotion, Inc. Spinal midline indicator
WO2004066884A1 (en) 2003-01-31 2004-08-12 Spinalmotion, Inc. Intervertebral prosthesis placement instrument
US20070003525A1 (en) * 2003-01-31 2007-01-04 Moehlenbruck Jeffrey W Hydrogel compositions comprising nucleus pulposus tissue
US20040158254A1 (en) * 2003-02-12 2004-08-12 Sdgi Holdings, Inc. Instrument and method for milling a path into bone
US7335203B2 (en) * 2003-02-12 2008-02-26 Kyphon Inc. System and method for immobilizing adjacent spinous processes
US7419505B2 (en) * 2003-04-22 2008-09-02 Fleischmann Lewis W Collapsible, rotatable, and tiltable hydraulic spinal disc prosthesis system with selectable modular components
US6969405B2 (en) * 2003-04-23 2005-11-29 Loubert Suddaby Inflatable intervertebral disc replacement prosthesis
WO2004105638A2 (en) 2003-05-27 2004-12-09 Spinalmotion, Inc. Prosthetic disc for intervertebral insertion
US10052211B2 (en) 2003-05-27 2018-08-21 Simplify Medical Pty Ltd. Prosthetic disc for intervertebral insertion
US7575599B2 (en) * 2004-07-30 2009-08-18 Spinalmotion, Inc. Intervertebral prosthetic disc with metallic core
US20090076614A1 (en) * 2007-09-17 2009-03-19 Spinalmotion, Inc. Intervertebral Prosthetic Disc with Shock Absorption Core
US20050015140A1 (en) * 2003-07-14 2005-01-20 Debeer Nicholas Encapsulation device and methods of use
DE112004001370B8 (en) * 2003-07-25 2010-06-10 Impliant Ltd. Elastomeric nucleus replacement
US6958077B2 (en) * 2003-07-29 2005-10-25 Loubert Suddaby Inflatable nuclear prosthesis
US7753958B2 (en) 2003-08-05 2010-07-13 Gordon Charles R Expandable intervertebral implant
US7909869B2 (en) 2003-08-05 2011-03-22 Flexuspine, Inc. Artificial spinal unit assemblies
US7799082B2 (en) 2003-08-05 2010-09-21 Flexuspine, Inc. Artificial functional spinal unit system and method for use
US20060229729A1 (en) * 2003-08-05 2006-10-12 Gordon Charles R Expandable intervertebral implant for use with instrument
US7632294B2 (en) * 2003-09-29 2009-12-15 Promethean Surgical Devices, Llc Devices and methods for spine repair
US7655012B2 (en) 2003-10-02 2010-02-02 Zimmer Spine, Inc. Methods and apparatuses for minimally invasive replacement of intervertebral discs
US20050090899A1 (en) * 2003-10-24 2005-04-28 Dipoto Gene Methods and apparatuses for treating the spine through an access device
US7361183B2 (en) 2003-10-17 2008-04-22 Ensure Medical, Inc. Locator and delivery device and method of use
US8852229B2 (en) * 2003-10-17 2014-10-07 Cordis Corporation Locator and closure device and method of use
ATE380530T1 (en) * 2003-10-17 2007-12-15 Co Ligne Ag FUSION IMPLANT
US9445916B2 (en) 2003-10-22 2016-09-20 Pioneer Surgical Technology, Inc. Joint arthroplasty devices having articulating members
US7320707B2 (en) * 2003-11-05 2008-01-22 St. Francis Medical Technologies, Inc. Method of laterally inserting an artificial vertebral disk replacement implant with crossbar spacer
US20050116400A1 (en) * 2003-11-14 2005-06-02 White Moreno J. Non-linear fiber/matrix architecture
US7691146B2 (en) * 2003-11-21 2010-04-06 Kyphon Sarl Method of laterally inserting an artificial vertebral disk replacement implant with curved spacer
US20050283237A1 (en) * 2003-11-24 2005-12-22 St. Francis Medical Technologies, Inc. Artificial spinal disk replacement device with staggered vertebral body attachments
US20050154462A1 (en) * 2003-12-02 2005-07-14 St. Francis Medical Technologies, Inc. Laterally insertable artificial vertebral disk replacement implant with translating pivot point
US20050209603A1 (en) * 2003-12-02 2005-09-22 St. Francis Medical Technologies, Inc. Method for remediation of intervertebral disks
US7217291B2 (en) * 2003-12-08 2007-05-15 St. Francis Medical Technologies, Inc. System and method for replacing degenerated spinal disks
US20050143826A1 (en) * 2003-12-11 2005-06-30 St. Francis Medical Technologies, Inc. Disk repair structures with anchors
US8012210B2 (en) * 2004-01-16 2011-09-06 Warsaw Orthopedic, Inc. Implant frames for use with settable materials and related methods of use
US20060275273A1 (en) * 2004-02-20 2006-12-07 Seyedin Mitchell S Intervertebral Disc Repair, Methods and Devices Therefor
EP1753860B1 (en) * 2004-02-20 2012-04-11 Isto Technologies Inc. Intervertebral disc repair and methods therefor
US20060135959A1 (en) * 2004-03-22 2006-06-22 Disc Dynamics, Inc. Nuclectomy method and apparatus
US20050209602A1 (en) * 2004-03-22 2005-09-22 Disc Dynamics, Inc. Multi-stage biomaterial injection system for spinal implants
JP2007530120A (en) * 2004-03-26 2007-11-01 ヌヴァシヴ インコーポレイテッド Porous implant for spinal disc nucleus pulposus replacement
US7452339B2 (en) * 2004-04-23 2008-11-18 Core Products International Inc. Pressure point therapeutic device
US7524324B2 (en) * 2004-04-28 2009-04-28 Kyphon Sarl System and method for an interspinous process implant as a supplement to a spine stabilization implant
US7585316B2 (en) * 2004-05-21 2009-09-08 Warsaw Orthopedic, Inc. Interspinous spacer
US20050273172A1 (en) * 2004-06-07 2005-12-08 Patil Arun A Artificial disc and uses therefor
US20060036258A1 (en) * 2004-06-08 2006-02-16 St. Francis Medical Technologies, Inc. Sizing distractor and method for implanting an interspinous implant between adjacent spinous processes
EP1778134A1 (en) * 2004-07-27 2007-05-02 Synthes USA Supplementation or replacement of a nucleus pulposus, of an intervertebral disc
US7585326B2 (en) 2004-08-06 2009-09-08 Spinalmotion, Inc. Methods and apparatus for intervertebral disc prosthesis insertion
US20060041313A1 (en) * 2004-08-19 2006-02-23 Sdgi Holdings, Inc. Intervertebral disc system
US8110003B2 (en) 2004-09-09 2012-02-07 University Of South Florida Prostheses for spine discs having fusion capability
US20060052870A1 (en) * 2004-09-09 2006-03-09 Ferree Bret A Methods and apparatus to prevent movement through artificial disc replacements
WO2006034436A2 (en) 2004-09-21 2006-03-30 Stout Medical Group, L.P. Expandable support device and method of use
US7303074B2 (en) * 2004-09-22 2007-12-04 Dombrowski Trudy M Foldable organizer device
US8012209B2 (en) * 2004-09-23 2011-09-06 Kyphon Sarl Interspinous process implant including a binder, binder aligner and method of implantation
US20060069438A1 (en) * 2004-09-29 2006-03-30 Zucherman James F Multi-piece artificial spinal disk replacement device with multi-segmented support plates
US7575600B2 (en) * 2004-09-29 2009-08-18 Kyphon Sarl Artificial vertebral disk replacement implant with translating articulation contact surface and method
US7481840B2 (en) * 2004-09-29 2009-01-27 Kyphon Sarl Multi-piece artificial spinal disk replacement device with selectably positioning articulating element
US20060089719A1 (en) * 2004-10-21 2006-04-27 Trieu Hai H In situ formation of intervertebral disc implants
US20060095134A1 (en) * 2004-10-28 2006-05-04 Sdgi Holdings, Inc. Materials, devices and methods for implantation of transformable implants
US20060106381A1 (en) * 2004-11-18 2006-05-18 Ferree Bret A Methods and apparatus for treating spinal stenosis
ATE524121T1 (en) 2004-11-24 2011-09-15 Abdou Samy DEVICES FOR PLACING AN ORTHOPEDIC INTERVERTEBRAL IMPLANT
US8029540B2 (en) 2005-05-10 2011-10-04 Kyphon Sarl Inter-cervical facet implant with implantation tool
US7776090B2 (en) 2004-12-13 2010-08-17 Warsaw Orthopedic, Inc. Inter-cervical facet implant and method
US8100944B2 (en) 2004-12-13 2012-01-24 Kyphon Sarl Inter-cervical facet implant and method for preserving the tissues surrounding the facet joint
US7806934B2 (en) * 2004-12-16 2010-10-05 Replication Medical Inc. Radially compressed dehydrated spinal nucleus implants
US20090264939A9 (en) * 2004-12-16 2009-10-22 Martz Erik O Instrument set and method for performing spinal nuclectomy
US8083797B2 (en) * 2005-02-04 2011-12-27 Spinalmotion, Inc. Intervertebral prosthetic disc with shock absorption
US8097018B2 (en) * 2005-02-17 2012-01-17 Kyphon Sarl Percutaneous spinal implants and methods
US8096995B2 (en) * 2005-02-17 2012-01-17 Kyphon Sarl Percutaneous spinal implants and methods
US7998174B2 (en) 2005-02-17 2011-08-16 Kyphon Sarl Percutaneous spinal implants and methods
US8043335B2 (en) * 2005-02-17 2011-10-25 Kyphon Sarl Percutaneous spinal implants and methods
US20060184248A1 (en) * 2005-02-17 2006-08-17 Edidin Avram A Percutaneous spinal implants and methods
US8157841B2 (en) * 2005-02-17 2012-04-17 Kyphon Sarl Percutaneous spinal implants and methods
US20070276493A1 (en) * 2005-02-17 2007-11-29 Malandain Hugues F Percutaneous spinal implants and methods
US20070055237A1 (en) * 2005-02-17 2007-03-08 Edidin Avram A Percutaneous spinal implants and methods
US8007521B2 (en) * 2005-02-17 2011-08-30 Kyphon Sarl Percutaneous spinal implants and methods
US8034080B2 (en) * 2005-02-17 2011-10-11 Kyphon Sarl Percutaneous spinal implants and methods
US7998208B2 (en) * 2005-02-17 2011-08-16 Kyphon Sarl Percutaneous spinal implants and methods
US20070276372A1 (en) * 2005-02-17 2007-11-29 Malandain Hugues F Percutaneous Spinal Implants and Methods
US8096994B2 (en) 2005-02-17 2012-01-17 Kyphon Sarl Percutaneous spinal implants and methods
US8092459B2 (en) * 2005-02-17 2012-01-10 Kyphon Sarl Percutaneous spinal implants and methods
US20080039944A1 (en) * 2005-02-17 2008-02-14 Malandain Hugues F Percutaneous Spinal Implants and Methods
US7927354B2 (en) * 2005-02-17 2011-04-19 Kyphon Sarl Percutaneous spinal implants and methods
US8038698B2 (en) * 2005-02-17 2011-10-18 Kphon Sarl Percutaneous spinal implants and methods
US20080288078A1 (en) * 2005-02-17 2008-11-20 Kohm Andrew C Percutaneous spinal implants and methods
US20070276373A1 (en) * 2005-02-17 2007-11-29 Malandain Hugues F Percutaneous Spinal Implants and Methods
US7993342B2 (en) 2005-02-17 2011-08-09 Kyphon Sarl Percutaneous spinal implants and methods
US8029567B2 (en) * 2005-02-17 2011-10-04 Kyphon Sarl Percutaneous spinal implants and methods
US8100943B2 (en) 2005-02-17 2012-01-24 Kyphon Sarl Percutaneous spinal implants and methods
US8057513B2 (en) * 2005-02-17 2011-11-15 Kyphon Sarl Percutaneous spinal implants and methods
US7988709B2 (en) * 2005-02-17 2011-08-02 Kyphon Sarl Percutaneous spinal implants and methods
JP2006253316A (en) * 2005-03-09 2006-09-21 Sony Corp Solid-state image sensing device
US8066742B2 (en) * 2005-03-31 2011-11-29 Warsaw Orthopedic, Inc. Intervertebral prosthetic device for spinal stabilization and method of implanting same
US20060241757A1 (en) * 2005-03-31 2006-10-26 Sdgi Holdings, Inc. Intervertebral prosthetic device for spinal stabilization and method of manufacturing same
US7862590B2 (en) 2005-04-08 2011-01-04 Warsaw Orthopedic, Inc. Interspinous process spacer
US7780709B2 (en) * 2005-04-12 2010-08-24 Warsaw Orthopedic, Inc. Implants and methods for inter-transverse process dynamic stabilization of a spinal motion segment
US8034079B2 (en) * 2005-04-12 2011-10-11 Warsaw Orthopedic, Inc. Implants and methods for posterior dynamic stabilization of a spinal motion segment
US7789898B2 (en) 2005-04-15 2010-09-07 Warsaw Orthopedic, Inc. Transverse process/laminar spacer
EP1868539A2 (en) * 2005-04-15 2007-12-26 Musculoskeletal Transplant Foundation Vertebral disc repair
US7182783B2 (en) * 2005-04-25 2007-02-27 Sdgi Holdings, Inc. Selectively expandable composite structures for spinal arthroplasty
WO2006116761A2 (en) * 2005-04-27 2006-11-02 Stout Medical Group, L.P. Expandable support device and methods of use
US20060247623A1 (en) * 2005-04-29 2006-11-02 Sdgi Holdings, Inc. Local delivery of an active agent from an orthopedic implant
US7727233B2 (en) * 2005-04-29 2010-06-01 Warsaw Orthopedic, Inc. Spinous process stabilization devices and methods
US20060253199A1 (en) * 2005-05-03 2006-11-09 Disc Dynamics, Inc. Lordosis creating nucleus replacement method and apparatus
US20060253198A1 (en) * 2005-05-03 2006-11-09 Disc Dynamics, Inc. Multi-lumen mold for intervertebral prosthesis and method of using same
US8088144B2 (en) * 2005-05-04 2012-01-03 Ensure Medical, Inc. Locator and closure device and method of use
US8926654B2 (en) 2005-05-04 2015-01-06 Cordis Corporation Locator and closure device and method of use
US8870915B2 (en) * 2005-05-04 2014-10-28 DePuy Synthes Products, LLC Joining element
US20070049849A1 (en) * 2005-05-24 2007-03-01 Schwardt Jeffrey D Bone probe apparatus and method of use
US7628800B2 (en) * 2005-06-03 2009-12-08 Warsaw Orthopedic, Inc. Formed in place corpectomy device
FR2887434B1 (en) 2005-06-28 2008-03-28 Jean Taylor SURGICAL TREATMENT EQUIPMENT OF TWO VERTEBRATES
WO2007009107A2 (en) * 2005-07-14 2007-01-18 Stout Medical Group, P.L. Expandable support device and method of use
US20070055379A1 (en) * 2005-08-03 2007-03-08 Stone Corbett W Annular access devices
CA2617932A1 (en) * 2005-08-09 2007-02-22 Trans1, Inc. Exchange system for axial spinal procedures
US20070074980A1 (en) * 2005-09-02 2007-04-05 Bankoski Brian R Implant rehydration packages and methods of use
US20070067036A1 (en) * 2005-09-20 2007-03-22 Zimmer Spine, Inc. Hydrogel total disc prosthesis
US8167915B2 (en) 2005-09-28 2012-05-01 Nuvasive, Inc. Methods and apparatus for treating spinal stenosis
US8357181B2 (en) * 2005-10-27 2013-01-22 Warsaw Orthopedic, Inc. Intervertebral prosthetic device for spinal stabilization and method of implanting same
US7862591B2 (en) * 2005-11-10 2011-01-04 Warsaw Orthopedic, Inc. Intervertebral prosthetic device for spinal stabilization and method of implanting same
US20070173823A1 (en) * 2006-01-18 2007-07-26 Sdgi Holdings, Inc. Intervertebral prosthetic device for spinal stabilization and method of implanting same
US8083795B2 (en) * 2006-01-18 2011-12-27 Warsaw Orthopedic, Inc. Intervertebral prosthetic device for spinal stabilization and method of manufacturing same
US7691130B2 (en) 2006-01-27 2010-04-06 Warsaw Orthopedic, Inc. Spinal implants including a sensor and methods of use
US7682376B2 (en) * 2006-01-27 2010-03-23 Warsaw Orthopedic, Inc. Interspinous devices and methods of use
US7837711B2 (en) * 2006-01-27 2010-11-23 Warsaw Orthopedic, Inc. Artificial spinous process for the sacrum and methods of use
US20070191838A1 (en) * 2006-01-27 2007-08-16 Sdgi Holdings, Inc. Interspinous devices and methods of use
US20070179614A1 (en) * 2006-01-30 2007-08-02 Sdgi Holdings, Inc. Intervertebral prosthetic disc and method of installing same
US20070191956A1 (en) * 2006-02-10 2007-08-16 Replication Medical, Inc. Radially extended support member for spinal nucleus implants and methods of use
WO2007095333A2 (en) * 2006-02-15 2007-08-23 Abdou M S Devices and methods for inter-vertebral orthopedic device placement
US20070233251A1 (en) * 2006-02-18 2007-10-04 Abdou M S Use of Magnetic Fields in Orthopedic Implants
US20070233068A1 (en) * 2006-02-22 2007-10-04 Sdgi Holdings, Inc. Intervertebral prosthetic assembly for spinal stabilization and method of implanting same
US7918889B2 (en) * 2006-02-27 2011-04-05 Warsaw Orthopedic, Inc. Expandable spinal prosthetic devices and associated methods
US8118869B2 (en) * 2006-03-08 2012-02-21 Flexuspine, Inc. Dynamic interbody device
US8262698B2 (en) * 2006-03-16 2012-09-11 Warsaw Orthopedic, Inc. Expandable device for insertion between anatomical structures and a procedure utilizing same
US20070233245A1 (en) * 2006-03-31 2007-10-04 Sdgi Holdings, Inc. Methods and instruments for delivering intervertebral devices
US7985246B2 (en) * 2006-03-31 2011-07-26 Warsaw Orthopedic, Inc. Methods and instruments for delivering interspinous process spacers
US8734519B2 (en) * 2006-04-12 2014-05-27 Spinalmotion, Inc. Posterior spinal device and method
FR2899788B1 (en) * 2006-04-13 2008-07-04 Jean Taylor TREATMENT EQUIPMENT FOR VERTEBRATES, COMPRISING AN INTEREPINOUS IMPLANT
US8303660B1 (en) 2006-04-22 2012-11-06 Samy Abdou Inter-vertebral disc prosthesis with variable rotational stop and methods of use
US8118844B2 (en) 2006-04-24 2012-02-21 Warsaw Orthopedic, Inc. Expandable device for insertion between anatomical structures and a procedure utilizing same
US20070255286A1 (en) * 2006-04-27 2007-11-01 Sdgi Holdings, Inc. Devices, apparatus, and methods for improved disc augmentation
US8133279B2 (en) * 2006-04-27 2012-03-13 Warsaw Orthopedic, Inc. Methods for treating an annulus defect of an intervertebral disc
US20070255406A1 (en) * 2006-04-27 2007-11-01 Sdgi Holdings, Inc. Devices, apparatus, and methods for bilateral approach to disc augmentation
US8048118B2 (en) * 2006-04-28 2011-11-01 Warsaw Orthopedic, Inc. Adjustable interspinous process brace
US8348978B2 (en) * 2006-04-28 2013-01-08 Warsaw Orthopedic, Inc. Interosteotic implant
US20070270823A1 (en) * 2006-04-28 2007-11-22 Sdgi Holdings, Inc. Multi-chamber expandable interspinous process brace
US8105357B2 (en) * 2006-04-28 2012-01-31 Warsaw Orthopedic, Inc. Interspinous process brace
US8252031B2 (en) * 2006-04-28 2012-08-28 Warsaw Orthopedic, Inc. Molding device for an expandable interspinous process implant
US20070270824A1 (en) * 2006-04-28 2007-11-22 Warsaw Orthopedic, Inc. Interspinous process brace
US7846185B2 (en) * 2006-04-28 2010-12-07 Warsaw Orthopedic, Inc. Expandable interspinous process implant and method of installing same
WO2007131002A2 (en) 2006-05-01 2007-11-15 Stout Medical Group, L.P. Expandable support device and method of use
US8062337B2 (en) * 2006-05-04 2011-11-22 Warsaw Orthopedic, Inc. Expandable device for insertion between anatomical structures and a procedure utilizing same
US20070276497A1 (en) * 2006-05-23 2007-11-29 Sdgi Holdings. Inc. Surgical spacer
US8147517B2 (en) * 2006-05-23 2012-04-03 Warsaw Orthopedic, Inc. Systems and methods for adjusting properties of a spinal implant
US20070276496A1 (en) * 2006-05-23 2007-11-29 Sdgi Holdings, Inc. Surgical spacer with shape control
US8092536B2 (en) * 2006-05-24 2012-01-10 Disc Dynamics, Inc. Retention structure for in situ formation of an intervertebral prosthesis
US20070276491A1 (en) * 2006-05-24 2007-11-29 Disc Dynamics, Inc. Mold assembly for intervertebral prosthesis
US8771355B2 (en) * 2006-05-26 2014-07-08 M. S. Abdou Inter-vertebral disc motion devices and methods of use
US20070276369A1 (en) * 2006-05-26 2007-11-29 Sdgi Holdings, Inc. In vivo-customizable implant
US20080004703A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic, Inc. Method of treating a patient using a collagen material
US8118779B2 (en) * 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
US8399619B2 (en) * 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
US20080004431A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic Inc Method of manufacturing an injectable collagen material
US20080021457A1 (en) * 2006-07-05 2008-01-24 Warsaw Orthopedic Inc. Zygapophysial joint repair system
US8048119B2 (en) * 2006-07-20 2011-11-01 Warsaw Orthopedic, Inc. Apparatus for insertion between anatomical structures and a procedure utilizing same
EP2076220A2 (en) * 2006-07-25 2009-07-08 Musculoskeletal Transplant Foundation Packed demineralized cancellous tissue forms for disc nucleus augmentation, restoration, or replacement and methods of implantation
US20080026032A1 (en) * 2006-07-27 2008-01-31 Zubery Yuval Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use
US20080051900A1 (en) * 2006-07-28 2008-02-28 Spinalmotion, Inc. Spinal Prosthesis with Offset Anchors
US20080051901A1 (en) 2006-07-28 2008-02-28 Spinalmotion, Inc. Spinal Prosthesis with Multiple Pillar Anchors
US8834526B2 (en) * 2006-08-09 2014-09-16 Rolando Garcia Methods and apparatus for treating spinal stenosis
US20080086115A1 (en) * 2006-09-07 2008-04-10 Warsaw Orthopedic, Inc. Intercostal spacer device and method for use in correcting a spinal deformity
FR2907329B1 (en) * 2006-10-20 2009-02-27 Jean Taylor INTEREPINEAL VERTEBRAL PROSTHESIS
EP2063808A4 (en) * 2006-09-14 2012-06-13 Spineology Inc Absorbent fabric implant
US8715350B2 (en) 2006-09-15 2014-05-06 Pioneer Surgical Technology, Inc. Systems and methods for securing an implant in intervertebral space
US8066750B2 (en) 2006-10-06 2011-11-29 Warsaw Orthopedic, Inc Port structures for non-rigid bone plates
US20080177298A1 (en) * 2006-10-24 2008-07-24 St. Francis Medical Technologies, Inc. Tensioner Tool and Method for Implanting an Interspinous Process Implant Including a Binder
US8097019B2 (en) * 2006-10-24 2012-01-17 Kyphon Sarl Systems and methods for in situ assembly of an interspinous process distraction implant
US20080108990A1 (en) * 2006-11-02 2008-05-08 St. Francis Medical Technologies, Inc. Interspinous process implant having a fixed wing and a deployable wing and method of implantation
FR2908035B1 (en) * 2006-11-08 2009-05-01 Jean Taylor INTEREPINE IMPLANT
US20080114358A1 (en) * 2006-11-13 2008-05-15 Warsaw Orthopedic, Inc. Intervertebral Prosthetic Assembly for Spinal Stabilization and Method of Implanting Same
US7879104B2 (en) * 2006-11-15 2011-02-01 Warsaw Orthopedic, Inc. Spinal implant system
US20080114455A1 (en) * 2006-11-15 2008-05-15 Warsaw Orthopedic, Inc. Rotating Interspinous Process Devices and Methods of Use
US20080114357A1 (en) * 2006-11-15 2008-05-15 Warsaw Orthopedic, Inc. Inter-transverse process spacer device and method for use in correcting a spinal deformity
US7955392B2 (en) 2006-12-14 2011-06-07 Warsaw Orthopedic, Inc. Interspinous process devices and methods
US20080154374A1 (en) * 2006-12-20 2008-06-26 Robert David Labrom Joint implant and a surgical method associated therewith
US7905922B2 (en) 2006-12-20 2011-03-15 Zimmer Spine, Inc. Surgical implant suitable for replacement of an intervertebral disc
US20080167655A1 (en) * 2007-01-05 2008-07-10 Jeffrey Chun Wang Interspinous implant, tools and methods of implanting
US8974496B2 (en) * 2007-08-30 2015-03-10 Jeffrey Chun Wang Interspinous implant, tools and methods of implanting
US9066811B2 (en) 2007-01-19 2015-06-30 Flexuspine, Inc. Artificial functional spinal unit system and method for use
US20080269903A1 (en) * 2007-04-25 2008-10-30 Warsaw Orthopedic, Inc. Intervertebral disc nucleus replacement implants and methods
US8840646B2 (en) 2007-05-10 2014-09-23 Warsaw Orthopedic, Inc. Spinous process implants and methods
US20080281361A1 (en) * 2007-05-10 2008-11-13 Shannon Marlece Vittur Posterior stabilization and spinous process systems and methods
US20080294199A1 (en) * 2007-05-25 2008-11-27 Andrew Kohm Spinous process implants and methods of using the same
FR2917287B1 (en) * 2007-06-15 2010-09-03 Ldr Medical INTERVERTEBRAL PROSTHESIS
US7942930B2 (en) * 2007-06-15 2011-05-17 Q-Med Ab Biocompatible implant system and method
US20090043391A1 (en) 2007-08-09 2009-02-12 Spinalmotion, Inc. Customized Intervertebral Prosthetic Disc with Shock Absorption
US8348976B2 (en) * 2007-08-27 2013-01-08 Kyphon Sarl Spinous-process implants and methods of using the same
US8162994B2 (en) 2007-10-22 2012-04-24 Flexuspine, Inc. Posterior stabilization system with isolated, dual dampener systems
US8523912B2 (en) 2007-10-22 2013-09-03 Flexuspine, Inc. Posterior stabilization systems with shared, dual dampener systems
US8157844B2 (en) 2007-10-22 2012-04-17 Flexuspine, Inc. Dampener system for a posterior stabilization system with a variable length elongated member
US8267965B2 (en) 2007-10-22 2012-09-18 Flexuspine, Inc. Spinal stabilization systems with dynamic interbody devices
US8182514B2 (en) 2007-10-22 2012-05-22 Flexuspine, Inc. Dampener system for a posterior stabilization system with a fixed length elongated member
US8187330B2 (en) * 2007-10-22 2012-05-29 Flexuspine, Inc. Dampener system for a posterior stabilization system with a variable length elongated member
US8758441B2 (en) * 2007-10-22 2014-06-24 Spinalmotion, Inc. Vertebral body replacement and method for spanning a space formed upon removal of a vertebral body
US20090149958A1 (en) * 2007-11-01 2009-06-11 Ann Prewett Structurally reinforced spinal nucleus implants
US8556949B2 (en) 2007-11-14 2013-10-15 DePuy Synthes Products, LLC Hybrid bone fixation element and methods of using the same
US8287538B2 (en) 2008-01-14 2012-10-16 Conventus Orthopaedics, Inc. Apparatus and methods for fracture repair
US8118873B2 (en) * 2008-01-16 2012-02-21 Warsaw Orthopedic, Inc. Total joint replacement
WO2009094477A1 (en) * 2008-01-25 2009-07-30 Spinalmotion, Inc. Compliant implantable prosthetic joint with preloaded spring
US20090198245A1 (en) * 2008-02-04 2009-08-06 Phan Christopher U Tools and methods for insertion and removal of medical implants
US8105358B2 (en) * 2008-02-04 2012-01-31 Kyphon Sarl Medical implants and methods
US8992620B2 (en) * 2008-12-10 2015-03-31 Coalign Innovations, Inc. Adjustable distraction cage with linked locking mechanisms
US20090222096A1 (en) * 2008-02-28 2009-09-03 Warsaw Orthopedic, Inc. Multi-compartment expandable devices and methods for intervertebral disc expansion and augmentation
US8764833B2 (en) * 2008-03-11 2014-07-01 Spinalmotion, Inc. Artificial intervertebral disc with lower height
US8114136B2 (en) 2008-03-18 2012-02-14 Warsaw Orthopedic, Inc. Implants and methods for inter-spinous process dynamic stabilization of a spinal motion segment
US8202299B2 (en) 2008-03-19 2012-06-19 Collabcom II, LLC Interspinous implant, tools and methods of implanting
US9034038B2 (en) * 2008-04-11 2015-05-19 Spinalmotion, Inc. Motion limiting insert for an artificial intervertebral disc
US20110125158A1 (en) 2008-05-01 2011-05-26 Ashish Dhar Diwan Systems, methods and apparatuses for formation and insertion of tissue prostheses
KR20110009216A (en) * 2008-05-05 2011-01-27 스피날모우션, 인코포레이티드 Polyaryletherketone artificial intervertebral disc
KR100977535B1 (en) * 2008-05-13 2010-08-23 윤강준 An artificial nucleus pulposus in the middle of the spinal disc
US7976578B2 (en) * 2008-06-04 2011-07-12 James Marvel Buffer for a human joint and method of arthroscopically inserting
WO2010002824A1 (en) * 2008-06-30 2010-01-07 Allergan, Inc. Fillable prosthetic implant with gel-like properties
US9220603B2 (en) * 2008-07-02 2015-12-29 Simplify Medical, Inc. Limited motion prosthetic intervertebral disc
EP2299944A4 (en) 2008-07-17 2013-07-31 Spinalmotion Inc Artificial intervertebral disc placement system
EP2299941A1 (en) * 2008-07-18 2011-03-30 Spinalmotion Inc. Posterior prosthetic intervertebral disc
US20100030549A1 (en) * 2008-07-31 2010-02-04 Lee Michael M Mobile device having human language translation capability with positional feedback
AU2009282577B2 (en) 2008-08-20 2015-04-16 Allergan, Inc. Self-sealing shell for inflatable prostheses
US20100094344A1 (en) * 2008-10-14 2010-04-15 Kyphon Sarl Pedicle-Based Posterior Stabilization Members and Methods of Use
US20100106252A1 (en) * 2008-10-29 2010-04-29 Kohm Andrew C Spinal implants having multiple movable members
US8114131B2 (en) * 2008-11-05 2012-02-14 Kyphon Sarl Extension limiting devices and methods of use for the spine
US20100211176A1 (en) 2008-11-12 2010-08-19 Stout Medical Group, L.P. Fixation device and method
US20100204795A1 (en) 2008-11-12 2010-08-12 Stout Medical Group, L.P. Fixation device and method
US7805920B2 (en) * 2008-11-13 2010-10-05 The Toro Company Lawn mower having steeply inclined exit tunnel and battery access through rear face of mower cutting deck
US8216316B2 (en) * 2008-12-17 2012-07-10 X-Spine Systems, Inc. Prosthetic implant with biplanar angulation and compound angles
US8114135B2 (en) * 2009-01-16 2012-02-14 Kyphon Sarl Adjustable surgical cables and methods for treating spinal stenosis
WO2010093950A1 (en) * 2009-02-12 2010-08-19 Osteotech, Inc. Delivery system cartridge
US20100268227A1 (en) * 2009-04-15 2010-10-21 Depuy Products, Inc. Methods and Devices for Bone Attachment
US8696759B2 (en) 2009-04-15 2014-04-15 DePuy Synthes Products, LLC Methods and devices for implants with calcium phosphate
US20100286701A1 (en) * 2009-05-08 2010-11-11 Kyphon Sarl Distraction tool for distracting an interspinous space
US8372117B2 (en) * 2009-06-05 2013-02-12 Kyphon Sarl Multi-level interspinous implants and methods of use
US8157842B2 (en) * 2009-06-12 2012-04-17 Kyphon Sarl Interspinous implant and methods of use
US20110077686A1 (en) * 2009-09-29 2011-03-31 Kyphon Sarl Interspinous process implant having a compliant spacer
US8771317B2 (en) * 2009-10-28 2014-07-08 Warsaw Orthopedic, Inc. Interspinous process implant and method of implantation
US20110112373A1 (en) * 2009-11-10 2011-05-12 Trans1 Inc. Soft tissue access apparatus and methods for spinal surgery
US8764806B2 (en) 2009-12-07 2014-07-01 Samy Abdou Devices and methods for minimally invasive spinal stabilization and instrumentation
US20110172720A1 (en) * 2010-01-13 2011-07-14 Kyphon Sarl Articulating interspinous process clamp
US8317831B2 (en) * 2010-01-13 2012-11-27 Kyphon Sarl Interspinous process spacer diagnostic balloon catheter and methods of use
US8114132B2 (en) * 2010-01-13 2012-02-14 Kyphon Sarl Dynamic interspinous process device
US8475536B2 (en) * 2010-01-29 2013-07-02 DePuy Synthes Products, LLC Methods and devices for implants with improved cement adhesion
WO2011097292A1 (en) 2010-02-05 2011-08-11 Allergan, Inc. Inflatable prostheses and methods of making same
US8636797B2 (en) 2010-02-05 2014-01-28 Allergan, Inc. Inflatable prostheses and methods of making same
US8147526B2 (en) * 2010-02-26 2012-04-03 Kyphon Sarl Interspinous process spacer diagnostic parallel balloon catheter and methods of use
US8449615B2 (en) 2010-04-18 2013-05-28 F.I.S.H., Llc Intervertebral implants having hydromagnetic joints
US8535380B2 (en) 2010-05-13 2013-09-17 Stout Medical Group, L.P. Fixation device and method
US8814908B2 (en) 2010-07-26 2014-08-26 Warsaw Orthopedic, Inc. Injectable flexible interspinous process device system
EP2608747A4 (en) 2010-08-24 2015-02-11 Flexmedex Llc Support device and method for use
US8353964B2 (en) 2010-11-04 2013-01-15 Carpenter Clyde T Anatomic total disc replacement
US9149286B1 (en) 2010-11-12 2015-10-06 Flexmedex, LLC Guidance tool and method for use
US8617240B2 (en) * 2010-11-17 2013-12-31 Charles D. Hightower Moldable cushion for implants
WO2012105647A1 (en) * 2011-02-04 2012-08-09 Hoya株式会社 Implement for surgery
US8562650B2 (en) 2011-03-01 2013-10-22 Warsaw Orthopedic, Inc. Percutaneous spinous process fusion plate assembly and method
US8388687B2 (en) 2011-03-25 2013-03-05 Flexuspine, Inc. Interbody device insertion systems and methods
US8591548B2 (en) 2011-03-31 2013-11-26 Warsaw Orthopedic, Inc. Spinous process fusion plate assembly
US8591549B2 (en) 2011-04-08 2013-11-26 Warsaw Orthopedic, Inc. Variable durometer lumbar-sacral implant
WO2013028808A1 (en) 2011-08-23 2013-02-28 Flexmedex, LLC Tissue removal device and method
US8845728B1 (en) 2011-09-23 2014-09-30 Samy Abdou Spinal fixation devices and methods of use
US9526627B2 (en) 2011-11-17 2016-12-27 Exactech, Inc. Expandable interbody device system and method
US9241807B2 (en) 2011-12-23 2016-01-26 Pioneer Surgical Technology, Inc. Systems and methods for inserting a spinal device
US20130226240A1 (en) 2012-02-22 2013-08-29 Samy Abdou Spinous process fixation devices and methods of use
US9155578B2 (en) 2012-02-28 2015-10-13 DePuy Synthes Products, Inc. Expandable fastener
CN104135949A (en) 2012-03-01 2014-11-05 新特斯有限责任公司 Surgical suture with soft core
US20130282121A1 (en) * 2012-03-22 2013-10-24 Ann Prewett Spinal facet augmentation implant and method
US9198767B2 (en) 2012-08-28 2015-12-01 Samy Abdou Devices and methods for spinal stabilization and instrumentation
US9320617B2 (en) 2012-10-22 2016-04-26 Cogent Spine, LLC Devices and methods for spinal stabilization and instrumentation
WO2014089711A1 (en) * 2012-12-11 2014-06-19 Dr.H.C. Robert Mathys Stiftung Bone substitute and method for producing same
EP2943131B1 (en) * 2013-01-09 2019-07-17 Cook Medical Technologies LLC Abdominal retractor
US9492288B2 (en) 2013-02-20 2016-11-15 Flexuspine, Inc. Expandable fusion device for positioning between adjacent vertebral bodies
US9913728B2 (en) 2013-03-14 2018-03-13 Quandary Medical, Llc Spinal implants and implantation system
US9345577B2 (en) 2013-03-14 2016-05-24 Microaire Surgical Instruments Llc Balloon implant device
US10327910B2 (en) 2013-03-14 2019-06-25 X-Spine Systems, Inc. Spinal implant and assembly
US10045786B2 (en) * 2013-12-20 2018-08-14 Microvention, Inc. Expansile member
US9517144B2 (en) 2014-04-24 2016-12-13 Exactech, Inc. Limited profile intervertebral implant with incorporated fastening mechanism
US10398565B2 (en) 2014-04-24 2019-09-03 Choice Spine, Llc Limited profile intervertebral implant with incorporated fastening and locking mechanism
US10857003B1 (en) 2015-10-14 2020-12-08 Samy Abdou Devices and methods for vertebral stabilization
EP3500209A4 (en) 2016-08-16 2020-03-18 Crosstex International, Inc. Valve for fluid ejector
US10744000B1 (en) 2016-10-25 2020-08-18 Samy Abdou Devices and methods for vertebral bone realignment
US10973648B1 (en) 2016-10-25 2021-04-13 Samy Abdou Devices and methods for vertebral bone realignment
US10631881B2 (en) 2017-03-09 2020-04-28 Flower Orthopedics Corporation Plating depth gauge and countersink instrument
WO2019010252A2 (en) 2017-07-04 2019-01-10 Conventus Orthopaedics, Inc. Apparatus and methods for treatment of a bone
JP2020533070A (en) 2017-09-08 2020-11-19 パイオニア サージカル テクノロジー インコーポレイテッド Intervertebral implants, instruments, and methods
USD907771S1 (en) 2017-10-09 2021-01-12 Pioneer Surgical Technology, Inc. Intervertebral implant
USD896383S1 (en) 2018-09-13 2020-09-15 Allergan, Inc. Tissue expansion device
CA3112634A1 (en) 2018-09-13 2020-03-19 Allergan, Inc. Tissue expansion device
US11179248B2 (en) 2018-10-02 2021-11-23 Samy Abdou Devices and methods for spinal implantation
US20230067769A1 (en) * 2021-08-27 2023-03-02 Acumed Llc Non-patient-specific craniofacial implants for correcting and/or preventing temporal or pterional deformities

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772287A (en) * 1987-08-20 1988-09-20 Cedar Surgical, Inc. Prosthetic disc and method of implanting
US5192326A (en) * 1990-12-21 1993-03-09 Pfizer Hospital Products Group, Inc. Hydrogel bead intervertebral disc nucleus

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3948254A (en) * 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US3883902A (en) * 1972-08-16 1975-05-20 Medical Eng Corp Variable volume prosthetic assembly
US3875595A (en) * 1974-04-15 1975-04-08 Edward C Froning Intervertebral disc prosthesis and instruments for locating same
CA1146301A (en) * 1980-06-13 1983-05-17 J. David Kuntz Intervertebral disc prosthesis
CH671691A5 (en) * 1987-01-08 1989-09-29 Sulzer Ag
US4863477A (en) * 1987-05-12 1989-09-05 Monson Gary L Synthetic intervertebral disc prosthesis
US5258043A (en) * 1987-07-20 1993-11-02 Regen Corporation Method for making a prosthetic intervertebral disc
US4911718A (en) * 1988-06-10 1990-03-27 University Of Medicine & Dentistry Of N.J. Functional and biocompatible intervertebral disc spacer
US5545229A (en) * 1988-08-18 1996-08-13 University Of Medicine And Dentistry Of Nj Functional and biocompatible intervertebral disc spacer containing elastomeric material of varying hardness
FR2639823A1 (en) * 1988-12-06 1990-06-08 Garcia Alain Replacement of the nucleus of the intervertebral disc by a polyurethane polymerised in situ
US4932975A (en) * 1989-10-16 1990-06-12 Vanderbilt University Vertebral prosthesis
DE8912648U1 (en) * 1989-10-23 1990-11-22 Mecron Medizinische Produkte Gmbh, 1000 Berlin, De
DE59100448D1 (en) * 1990-04-20 1993-11-11 Sulzer Ag Implant, in particular intervertebral prosthesis.
US5047055A (en) * 1990-12-21 1991-09-10 Pfizer Hospital Products Group, Inc. Hydrogel intervertebral disc nucleus
US5390683A (en) * 1991-02-22 1995-02-21 Pisharodi; Madhavan Spinal implantation methods utilizing a middle expandable implant
JP3007903B2 (en) * 1991-03-29 2000-02-14 京セラ株式会社 Artificial disc
US5320644A (en) * 1991-08-30 1994-06-14 Sulzer Brothers Limited Intervertebral disk prosthesis
US5425773A (en) * 1992-01-06 1995-06-20 Danek Medical, Inc. Intervertebral disk arthroplasty device
DE4208116C2 (en) * 1992-03-13 1995-08-03 Link Waldemar Gmbh Co Intervertebral disc prosthesis
US5306309A (en) * 1992-05-04 1994-04-26 Calcitek, Inc. Spinal disk implant and implantation kit
ATE205069T1 (en) * 1993-02-09 2001-09-15 Acromed Corp DISC
US5534028A (en) * 1993-04-20 1996-07-09 Howmedica, Inc. Hydrogel intervertebral disc nucleus with diminished lateral bulging
FR2707480B1 (en) * 1993-06-28 1995-10-20 Bisserie Michel Intervertebral disc prosthesis.
FR2709949B1 (en) * 1993-09-14 1995-10-13 Commissariat Energie Atomique Intervertebral disc prosthesis.
US5443514A (en) * 1993-10-01 1995-08-22 Acromed Corporation Method for using spinal implants
US5514180A (en) * 1994-01-14 1996-05-07 Heggeness; Michael H. Prosthetic intervertebral devices
US5458642A (en) * 1994-01-18 1995-10-17 Beer; John C. Synthetic intervertebral disc
US5571189A (en) * 1994-05-20 1996-11-05 Kuslich; Stephen D. Expandable fabric implant for stabilizing the spinal motion segment
WO1996011642A1 (en) * 1994-10-17 1996-04-25 Raymedica, Inc. Prosthetic spinal disc nucleus
US5674296A (en) * 1994-11-14 1997-10-07 Spinal Dynamics Corporation Human spinal disc prosthesis
US5705780A (en) * 1995-06-02 1998-01-06 Howmedica Inc. Dehydration of hydrogels
US5702449A (en) * 1995-06-07 1997-12-30 Danek Medical, Inc. Reinforced porous spinal implants
US5645597A (en) * 1995-12-29 1997-07-08 Krapiva; Pavel I. Disc replacement method and apparatus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772287A (en) * 1987-08-20 1988-09-20 Cedar Surgical, Inc. Prosthetic disc and method of implanting
US5192326A (en) * 1990-12-21 1993-03-09 Pfizer Hospital Products Group, Inc. Hydrogel bead intervertebral disc nucleus

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU761528B2 (en) * 1999-04-05 2003-06-05 Raymedica, Llc Prosthetic spinal disc nucleus having a shape change characteristic
WO2000059412A1 (en) * 1999-04-05 2000-10-12 Raymedica, Inc. Prosthetic spinal disc nucleus having a shape change characteristic
EP1623687A1 (en) * 1999-04-05 2006-02-08 Raymedica, Inc. Prosthetic spinal disc nucleus having a shape change characteristic
US7326249B2 (en) 2001-02-28 2008-02-05 Warsaw Orthopedic, Inc. Flexible spine stabilization systems
US6652585B2 (en) 2001-02-28 2003-11-25 Sdgi Holdings, Inc. Flexible spine stabilization system
US6827743B2 (en) 2001-02-28 2004-12-07 Sdgi Holdings, Inc. Woven orthopedic implants
US6852128B2 (en) 2001-02-28 2005-02-08 Sdgi Holdings, Inc. Flexible spine stabilization systems
US7041138B2 (en) 2001-02-28 2006-05-09 Sdgi Holdings, Inc. Flexible spine stabilization systems
US7341601B2 (en) 2001-02-28 2008-03-11 Warsaw Orthopedic, Inc. Woven orthopedic implants
US7229441B2 (en) 2001-02-28 2007-06-12 Warsaw Orthopedic, Inc. Flexible systems for spinal stabilization and fixation
US7641691B2 (en) 2001-06-29 2010-01-05 The Regents Of The University Of California Biodegradable/bioactive nucleus pulposus implant and method for treating degenerated intervertebral discs
US7156877B2 (en) 2001-06-29 2007-01-02 The Regents Of The University Of California Biodegradable/bioactive nucleus pulposus implant and method for treating degenerated intervertebral discs
US7682392B2 (en) 2002-10-30 2010-03-23 Depuy Spine, Inc. Regenerative implants for stabilizing the spine and devices for attachment of said implants
WO2005002474A1 (en) * 2003-07-02 2005-01-13 Jong Wuk Jang Disk therapy implant, and operation method of implant
WO2011136824A1 (en) * 2010-04-27 2011-11-03 Adnan Iqbal Qureshi Intraspinal device deployed through percutaneous approach into subarachnoid or intradural space of vertebral canal to protect spinal cord from external compression
US8876870B2 (en) 2010-04-27 2014-11-04 Adnan Iqbal Qureshi Intraspinal device deployed through percutaneous approach into subarachnoid or intradural space of vertebral canal to protect spinal cord from external compression

Also Published As

Publication number Publication date
JP2002506678A (en) 2002-03-05
US6022376A (en) 2000-02-08
JP2007289728A (en) 2007-11-08
JP2006116327A (en) 2006-05-11
ATE355802T1 (en) 2007-03-15
CA2323922A1 (en) 1999-09-23
ES2283108T3 (en) 2007-10-16
DE69935425D1 (en) 2007-04-19
EP1063948A4 (en) 2003-03-05
CA2323922C (en) 2004-03-09
KR100647762B1 (en) 2006-11-23
KR20010041891A (en) 2001-05-25
DE69935425T2 (en) 2007-10-31
EP1063948B1 (en) 2007-03-07
AU3007699A (en) 1999-10-11
EP1063948A1 (en) 2001-01-03
ZA200005580B (en) 2002-03-11
AU742901B2 (en) 2002-01-17
JP4105721B2 (en) 2008-06-25
BR9908824A (en) 2001-12-18

Similar Documents

Publication Publication Date Title
EP1063948B1 (en) Percutaneous prosthetic spinal disc nucleus and method of manufacture
AU761528B2 (en) Prosthetic spinal disc nucleus having a shape change characteristic
US6132465A (en) Tapered prosthetic spinal disc nucleus
AU743053B2 (en) Prosthetic spinal disc nucleus
EP0786963B1 (en) Prosthetic spinal disc nucleus
US6533817B1 (en) Packaged, partially hydrated prosthetic disc nucleus
AU768415B2 (en) Prosthetic spinal disc nucleus having selectively coupled bodies
WO1996011642A9 (en) Prosthetic spinal disc nucleus

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2323922

Country of ref document: CA

Ref country code: CA

Ref document number: 2323922

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1020007010193

Country of ref document: KR

Ref document number: 30076/99

Country of ref document: AU

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 536325

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000/05580

Country of ref document: ZA

Ref document number: 200005580

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 1999911436

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999911436

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1020007010193

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 30076/99

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 1020007010193

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 1999911436

Country of ref document: EP